<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">eNeuro</journal-id>
<journal-id journal-id-type="iso-abbrev">eNeuro</journal-id>
<journal-id journal-id-type="hwp">eneuro</journal-id>
<journal-id journal-id-type="pmc">eneuro</journal-id>
<journal-id journal-id-type="publisher-id">eNeuro</journal-id>
<journal-title-group>
<journal-title>eNeuro</journal-title>
</journal-title-group>
<issn pub-type="epub">2373-2822</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29464197</article-id>
<article-id pub-id-type="pmc">5818552</article-id>
<article-id pub-id-type="doi">10.1523/ENEURO.0194-17.2018</article-id>
<article-id pub-id-type="publisher-id">eN-NWR-0194-17</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>3</subject>
<subject>3.1</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Research</subject>
<subj-group>
<subject>Disorders of the Nervous System</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>MeCP2 Deficiency Leads to Loss of Glial Kir4.1</article-title>
<alt-title alt-title-type="left-running-head">Kir4.1 Is a Target of MeCP2</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-6203-7103</contrib-id>
<name>
<surname>Kahanovitch</surname>
<given-names>Uri</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="FN4">
<sup>*</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cuddapah</surname>
<given-names>Vishnu A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="FN4">
<sup>*</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pacheco</surname>
<given-names>Natasha L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="FN4">
<sup>*</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Holt</surname>
<given-names>Leanne M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-7040-3927</contrib-id>
<name>
<surname>Mulkey</surname>
<given-names>Daniel K.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Percy</surname>
<given-names>Alan K.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-1394-664X</contrib-id>
<name>
<surname>Olsen</surname>
<given-names>Michelle L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<aff id="aff1"><label>1</label>Department of Cell, Developmental and Integrative Biology, <institution>University of Alabama at Birmingham</institution>, Birmingham, AL 35294</aff>
<aff id="aff2"><label>2</label>Department of Pediatrics, Civitan International Research Center, <institution>University of Alabama at Birmingham</institution>, Birmingham, AL 35294</aff>
<aff id="aff3"><label>3</label><institution>Virginia Tech School of Neuroscience</institution>, Blacksburg, VA 24061</aff>
<aff id="aff4"><label>4</label>Department of Physiology and Neurobiology, <institution>University of Connecticut</institution>, Storrs, CT 06269, <country>USA</country></aff>
</contrib-group>
<author-notes>
<fn fn-type="other">
<p>The authors declare no competing financial interests.</p>
</fn>
<fn fn-type="con">
<p>Author contributions: U.K., V.A.C., N.L.P., L.M.H., and M.L.O. performed research; U.K., V.A.C., N.L.P., L.M.H., and M.L.O. analyzed data; U.K., V.A.C., N.L.P., L.M.H., D.K.M., and M.L.O. wrote the paper; V.A.C., N.L.P., and M.L.O. designed research; A.K.P. contributed unpublished reagents/analytic tools.</p>
</fn>
<fn fn-type="supported-by">
<p>This work was supported by International Rett Syndrome Foundation for Basic Research Grant (#2916) to MLO, National Institutes of Health grants NS075062 (MLO) and HL104101 (MLO, DKM), the UAB CCTS (grant number 5UL1RR025777) for a pilot grant to MLO, and the Civitan International Research Center for funding to VAC. NLP was funded in part by a grant to the University of Alabama at Birmingham from the Howard Hughes Medical Institute through the Med into Grad Initiative. Additional funds were also provided by Connecticut Department of Public Health Grant 150263 (DKM).</p>
</fn>
<fn fn-type="equal" id="FN4">
<label>*</label>
<p>U.K., V.A.C., and N.L.P. contributed equally to this work.</p>
</fn>
<corresp id="cor1">Correspondence should be addressed to Michelle Olsen, PhD, School of Neuroscience, Life Sciences Building RM 213, 970 Washington St. SW, Blacksburg VA, 24061. E-mail: <email>molsen1@vt.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="epreprint">
<day>12</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<season>Jan-Feb</season>
<year>2018</year>
</pub-date>
<volume>5</volume>
<issue>1</issue>
<elocation-id>ENEURO.0194-17.2018</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>1</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Kahanovitch et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Kahanovitch et al.</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="ENEURO.0194-17.2018.pdf"></self-uri>
<self-uri xlink:href="enu00118254900g1.jpg" xlink:role="icon"></self-uri>
<abstract abstract-type="graphical">
<title>Visual Abstract</title>
<p>
<fig fig-type="featured" id="F8" orientation="portrait" position="float">
<graphic xlink:href="enu001182549r001"></graphic>
</fig>
</p>
</abstract>
<abstract>
<title>Abstract</title>
<p>Rett syndrome (RTT) is an X-linked neurodevelopmental disorder usually caused by mutations in methyl-CpG-binding protein 2 (MeCP2). RTT is typified by apparently normal development until 6–18 mo of age, when motor and communicative skills regress and hand stereotypies, autonomic symptoms, and seizures present. Restoration of MeCP2 function selectively to astrocytes reversed several deficits in a murine model of RTT, but the mechanism of this rescue is unknown. Astrocytes carry out many essential functions required for normal brain functioning, including extracellular K<sup>+</sup> buffering. Kir4.1, an inwardly rectifying K<sup>+</sup> channel, is largely responsible for the channel-mediated K<sup>+</sup> regulation by astrocytes. Loss-of-function mutations in Kir4.1 in human patients result in a severe neurodevelopmental disorder termed EAST or SESAME syndrome. Here, we evaluated astrocytic Kir4.1 expression in a murine model of Rett syndrome. We demonstrate by chromatin immunoprecipitation analysis that Kir4.1 is a direct molecular target of MeCP2. Astrocytes from <italic>Mecp2</italic>-deficient mice express significantly less Kir4.1 mRNA and protein, which translates into a &gt;50% deficiency in Ba<sup>2+</sup>-sensitive Kir4.1-mediated currents, and impaired extracellular potassium dynamics. By examining astrocytes in isolation, we demonstrate that loss of Kir4.1 is cell autonomous. Assessment through postnatal development revealed that Kir4.1 expression in <italic>Mecp2</italic>-deficient animals never reaches adult, wild-type levels, consistent with a neurodevelopmental disorder. These are the first data implicating a direct MeCP2 molecular target in astrocytes and provide novel mechanistic insight explaining a potential mechanism by which astrocytic dysfunction may contribute to RTT.</p>
</abstract>
<kwd-group>
<kwd>Epigenetic regulation</kwd>
<kwd>Kcnj10</kwd>
<kwd>MeCP2</kwd>
<kwd>Rett syndrome</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source><named-content content-type="funder-id">http://doi.org/10.13039/100001819</named-content>International Rett Syndrome Foundation (IRSF)</funding-source>
<award-id>2916</award-id>
</award-group>
<award-group>
<funding-source><named-content content-type="funder-id">http://doi.org/10.13039/100000002</named-content>HHS | National Institutes of Health (NIH)</funding-source>
<award-id>RO1 NSO75062</award-id>
<award-id>RO1 HL104101</award-id>
</award-group>
<award-group>
<funding-source>UAB CCTS</funding-source>
<award-id>5UL1RR025777</award-id>
</award-group>
<award-group>
<funding-source><named-content content-type="funder-id">http://doi.org/10.13039/100006464</named-content>Civitan International</funding-source>
</award-group>
<award-group>
<funding-source><named-content content-type="funder-id">http://doi.org/10.13039/100000011</named-content>Howard Hughes Medical Institute (HHMI)</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="8"></fig-count>
<table-count count="2"></table-count>
<equation-count count="4"></equation-count>
<ref-count count="72"></ref-count>
<page-count count="15"></page-count>
<word-count count="10687"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January/February 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Significance Statement</title>
<p>Rett syndrome is a devastating neurodevelopmental disorder that affects 1 in 10,000–25,000 females. Mutations in methyl-CpG-binding protein 2 (MeCP2), a transcriptional regulator, are responsible for &gt;95% of RTT cases. Recent work has shown that astrocytes contribute significantly to the disorder, although their contribution to this disease is not known. Here, we demonstrate that the critical astrocyte K<sup>+</sup> channel Kir4.1 is a novel molecular target of MeCP2. MeCP2 deficiency leads to decreased <italic>Kcnj10</italic>/Kir4.1 mRNA levels, protein expression, and currents. These findings provide novel mechanistic insight and begin to elucidate the role of astrocytes in this disorder.</p>
</sec>
<sec id="s2" sec-type="intro">
<title>Introduction</title>
<p>Rett syndrome (RTT) is an X-linked neurodevelopmental disorder that affects 1 in 10,000–25,000 females (<xref ref-type="bibr" rid="B54">Percy, 2002</xref>). RTT is characterized by apparently normal development until 6–18 mo of age, when deficits in speech, ambulation, and hand use (e.g., hand wringing, clapping) become apparent (<xref ref-type="bibr" rid="B47">Neul et al., 2010</xref>). Breathing disturbances, scoliosis, diminished pain response, and seizures are also commonly associated with RTT (<xref ref-type="bibr" rid="B27">Jian et al., 2007</xref>; <xref ref-type="bibr" rid="B24">Glaze et al., 2010</xref>; <xref ref-type="bibr" rid="B47">Neul et al., 2010</xref>). More than 95% of girls with RTT have a mutation in the methyl-CpG-binding protein 2 (<italic>MECP2</italic>) gene located on the X-chromosome (<xref ref-type="bibr" rid="B14">Cuddapah et al., 2014</xref>). Knockout or mutation of <italic>Mecp2</italic> in mice recapitulates symptoms associated with RTT (<xref ref-type="bibr" rid="B10">Chen et al., 2001</xref>; <xref ref-type="bibr" rid="B25">Guy et al., 2001</xref>). Functionally, MeCP2 is a methyl-CpG–binding protein, which binds methylated and unmethylated DNA to modulate gene activity, and can act as a repressor or an activator of gene transcription depending on the context (<xref ref-type="bibr" rid="B9">Chahrour et al., 2008</xref>).</p>
<p>MeCP2 is most highly expressed in neurons, but it is also expressed in glia cells (<xref ref-type="bibr" rid="B2">Ballas et al., 2009</xref>; <xref ref-type="bibr" rid="B30">Kifayathullah et al., 2010</xref>; <xref ref-type="bibr" rid="B68">Zachariah et al., 2012</xref>; <xref ref-type="bibr" rid="B40">Liu et al., 2015, 2017</xref>). In addition, there are indications that astrocytic dysfunction plays a role in the pathophysiology of RTT. RTT astrocytes are abnormal (<xref ref-type="bibr" rid="B43">Maezawa et al., 2009</xref>), with altered microtubule assembly (<xref ref-type="bibr" rid="B46">Nectoux et al., 2012</xref>) and glutamate clearance (<xref ref-type="bibr" rid="B51">Okabe et al., 2012</xref>). Also, when cultured with MeCP2-deficient glia, wild-type (WT) neurons display aberrant morphology (<xref ref-type="bibr" rid="B2">Ballas et al., 2009</xref>; <xref ref-type="bibr" rid="B65">Williams et al., 2014</xref>). Specific deletion of MeCP2 in astrocytes also resulted in disturbed breathing patterns (<xref ref-type="bibr" rid="B22">Garg et al., 2015</xref>). Importantly, postnatal re-expression of MeCP2 in astrocytes in globally <italic>Mecp2</italic>-deficient mice improved locomotion, decreased anxiety, increased lifespan, and normalized respiration, neuronal cell size, and dendritic morphology (<xref ref-type="bibr" rid="B38">Lioy et al., 2011</xref>). However, to date, few direct molecular links between astrocytes and astrocytic dysfunction in animal models of RTT have been demonstrated. Possibly shedding some light on this question, a recent transcriptomic study in MeCP2-deficient mice indicates that 46 genes that are unique to astrocytes are disrupted in RTT, one being <italic>Kcnj10</italic>, the gene that codes for Kir4.1 (Pacheco et al., 2017).
</p>
<p><italic>Kcnj10</italic> expression is in the top 1% of all expressed genes in astrocytes (<xref ref-type="bibr" rid="B71">Zheng et al., 2014</xref>). Underscoring the relative importance of this channel, knockout or mutation of <italic>KCNJ10</italic> causes seizures, ataxia, and developmental deficits in mice and humans alike (<xref ref-type="bibr" rid="B20">Djukic et al., 2007</xref>; <xref ref-type="bibr" rid="B5">Bockenhauer et al., 2009</xref>; <xref ref-type="bibr" rid="B58">Scholl et al., 2009</xref>). Direct evidence that loss of Kir4.1 alters neuronal function was recently demonstrated in a mouse model of Huntington’s disease, where AAV-mediated restoration of Kir4.1 expression specifically to astrocytes reduced the concentration of extracellular K<sup>+</sup> ([K<sup>+</sup>]<sub>o</sub>), prolonged survival, and ameliorated motor abnormalities observed in these mice (<xref ref-type="bibr" rid="B63">Tong et al., 2014</xref>). Furthermore, a compound heterozygous change (two missense mutations) in <italic>KCNJ10</italic> was reported in a patient with RTT-like symptoms who lacked a mutation in <italic>MECP2</italic> (<xref ref-type="bibr" rid="B57">Sajan et al., 2017</xref>).</p>
<p>In the current study, we demonstrate that Kir4.1 is a direct molecular target of MeCP2. <italic>In situ</italic>, astrocytes from <italic>Mecp2</italic>-deficient mice show smaller astrocytic K<sup>+</sup> currents, with concomitant significant reductions in Kir4.1 protein and transcription. These data suggest MeCP2 is a positive regulator of <italic>Kcnj10</italic> gene expression through development and potentially provide insight explaining how astrocytic dysfunction may contribute to RTT.</p>
</sec>
<sec id="s3" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s3A">
<title>Animals</title>
<p>All animal procedures were performed in accordance with the [Author University] animal care committee’s regulations. Every effort was made to minimize pain and discomfort. WT males were bred with heterozygous <italic>Mecp2<sup>tm1.1Jae</sup></italic> (Jaenisch mutation) female mice, which lack exon 3 in the <italic>Mecp2</italic> gene (<xref ref-type="bibr" rid="B10">Chen et al., 2001</xref>). Genotypes of offspring were confirmed by PCR of DNA isolated from tail clips. Mutant male mice (<italic>Mecp2<sup>–/y</sup></italic>) were used for experimentation after postnatal day 50 (P50) when symptomatic, as demonstrated by hypoactivity and hindlimb clasping on suspension from tail compared with WT littermates of the same age. Symptomatic mutant female mice (<italic>Mecp2</italic>±) were used for experimentation at 7–8 mo of age and compared with WT female mice of the same age. All animals were on a C57BL/6 background.</p>
</sec>
<sec id="s3B">
<title>Western blotting</title>
<p>Animals were anesthetized with CO<sub>2</sub> and quickly decapitated. Brains were removed and placed in ice-cold PBS. Under a binocular microscope, the cerebellum and brainstem were removed, and the cortex was separated from hippocampus and midbrain. Cortex, hippocampus, midbrain, cerebellum, and brainstem were collected. Briefly, tissue was placed in ice-cold homogenization buffer (100 m<sc>m</sc> Tris, pH 7.5, 1% SDS at 50 mg/ml) supplemented with protease and phosphatase inhibitors (Sigma-Aldrich) and sonicated for 10 s. Tissue homogenates were centrifuged for 5 min at 12,000 × <italic>g</italic> at 4°C. Protein quantification was performed on the supernatant using a DC protein assay kit from Bio-Rad. Protein was heated to 60°C for 15 min in an equal volume of 2× sample buffer (100 m<sc>m</sc> Tris, pH 6.8, 10% SDS in Laemmli-SDS, and 600 m<sc>m</sc> β-mercaptoethanol). Equal amounts of protein were loaded into a 4%–20% gradient precast SDS gel (Bio-Rad). Gels were transferred at 100 V for 1 h at room temperature to PDVF membrane (Millipore). Membranes were blocked in blocking buffer (10% dried milk in TBST) for 1 h before probing with antibodies. The blots were probed with rabbit anti-Kir4.1 (Alomone, 1:1000 for 1 h), washed three times in TBST, and probed with an HRP-conjugated secondary antibody (Santa Cruz Biotechnology) for 1 h. After three 10-min washes, membranes were developed with Classico chemiluminescent reagent (Millipore) using a Kodak film developing system (Kodak). The blots were then stripped and reprobed for chicken anti-GAPDH (Abcam, 1:2000 for 1 h) or rabbit anti–β-tubulin (Millipore, 1:5000 for 30 min), which was used as a loading control. Protein expression was quantified using ImageJ. Target protein was normalized to GAPDH expression in the same lane. Both tetrameric (∼150-kDa) and monomeric (∼50-kDa) Kir4.1 isoforms were detected (e.g., <xref ref-type="fig" rid="F3">Fig. 3<italic>A</italic></xref>) that are specific to Kir4.1, as they are not present in <italic>Kcnj10</italic> knockout animals or negative control lysates (<xref ref-type="bibr" rid="B52">Olsen et al., 2006</xref>). The analysis included the entire lane (both isoforms). Cortical and brainstem Western blots were run in triplicate or quadruplicate. Human embryonic kidney (HEK) cell lysates were used as a negative control for astrocytic proteins on Western blots. Relative amounts of protein are reported.</p>
</sec>
<sec id="s3C">
<title>Quantitative PCR</title>
<p>mRNA was isolated from either cultured astrocytes or cortical and brainstem tissue collected as above using an RNA isolation kit (Qiagen). mRNA was converted to cDNA using the VILO Superscript kit (Life Technologies). Quantitative real-time PCR was run using TaqMan specific probes (all from Life Sciences) for <italic>Kcnj10</italic> (Kir4.1, Mm00445028_m1), Gfap (GFAP, Mm01253033), <italic>Hexb</italic> (hexosaminidase B, Mm01282432_m1), <italic>Tmem119</italic> (transmembrane protein 119, Mm00525305_m1), <italic>Mbp</italic> (myelin basic protein, Mm01266402_m1), <italic>Rbfox3</italic> (NeuN, Mm01248771_m1), and <italic>Gapdh</italic> (GAPDH, Mm99999915_g1). All probes span exon boundaries and as such only amplify mRNA. Each sample was run in triplicate and normalized to <italic>Gapdh</italic>, and the comparative Ct method was used to calculate changes in gene expression.</p>
</sec>
<sec id="s3D">
<title>Astrocyte isolation</title>
<p>Astrocyte isolation was performed according to <xref ref-type="bibr" rid="B26">Holt and Olsen (2016)</xref>. Briefly, mice were anesthetized with CO<sub>2</sub> and rapidly decapitated, and their cortices were microdissected in ice-cold cutting solution (120 m<sc>m</sc> NaCl, 3 m<sc>m</sc> KCl, 2 m<sc>m</sc> MgCl<sub>2</sub>, 0.2 m<sc>m</sc> CaCl<sub>2</sub>, 26.2 m<sc>m</sc> NaHCO<sub>3</sub>, 11.1 m<sc>m</sc> glucose, and 5 m<sc>m</sc> Hepes), supplemented with AP5 (3 m<sc>m</sc>) and CNQX (3 m<sc>m</sc>) and bubbled with 95% oxygen. The tissue was minced and enzymatically dissociated with a Papain Dissociation kit (Worthington) following manufacturer’s instructions. After dissociation, myelin debris and microglia were removed using a Myelin Removal Kit (Miltenyi Biotec) and Cd11b<sup>+</sup> Microbeads (Miltenyi Biotec), respectively. Astrocytes were then acutely isolated using anti–ACSA-2<sup>+</sup> (astrocyte cell surface antigen 2) MicroBead kit (Miltenyi Biotec). The ASCA-2<sup>+</sup> epitope is from the astrocyte-specific β2 subunit of the sodium potassium exchanger (<xref ref-type="bibr" rid="B3">Batiuk et al., 2017</xref>). The anti–ACSA-2<sup>+</sup> antibody is highly specific for astrocytes (<xref ref-type="bibr" rid="B26">Holt and Olsen, 2016</xref>), is robustly expressed in astrocytes (<xref ref-type="bibr" rid="B29">Kantzer et al., 2017</xref>), and is used as a first choice for isolating astrocytes (<xref ref-type="bibr" rid="B3">Batiuk et al., 2017</xref>). Manufacturer instructions were generally followed, except incubation times were extended to 25 min and total volume of microbeads was increased to 20–40 μl.</p>
</sec>
<sec id="s3E">
<title>Primary astrocyte cultures</title>
<p>Astrocytes from RTT or WT littermates were isolated from P3–P6 pups as described above. Astrocytes were plated on 13-mm glass coverslips coated with poly-<sc>l</sc>-ornithine and laminin in 24-well plates at a density of 1.0 × 10<sup>5</sup> cells. Astrocytes were maintained in serum-free media (50% Neurobasal Medium (Thermo Fisher Scientific), 50% MEM, 1 m<sc>m</sc> sodium pyruvate, 2 m<sc>m</sc> glutamine, and B27). Medium was changed every day for 3 consecutive days, with subsequent media changes every 3–4 d. RNA was collected after 7 and 14 days <italic>in vitro</italic> (DIV) using Ambion’s PureLink RNA Isolation Kit.</p>
</sec>
<sec id="s3F">
<title>Primary astrocyte culture immunohistochemistry</title>
<p>Astrocytes were fixed for immunofluorescence after 7 DIV. Cells were first washed with cold PBS, followed by fixation with 4% paraformaldehyde for 15 min at room temperature. Subsequently, cells were incubated for 1 h in blocking buffer (10% goat serum, 0.3% Triton X-100 in PBS). Astrocyte processes were stained with overnight incubation with Dako anti-rabbit GFAP (Z0334) at 1:1000 concentration. Fluorescent images were acquired with an Olympus VS-120 system.</p>
</sec>
<sec id="s3G">
<title>Acute brain slice preparation</title>
<p>Mice were anesthetized with CO<sub>2</sub> and rapidly decapitated. Brain was quickly isolated and placed in icy artificial cerebrospinal fluid (ACSF) cutting solution (see above). All solutions were continuously bubbled with 95% O<sub>2</sub>/5% CO<sub>2</sub> to bring to pH 7.4. Coronal 300-μm slices were cut with a Leica VT1000A vibratome and placed in ACSF at room temperature containing the following in m<sc>m</sc>: 120 NaCl, 3 KCl, 1 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 26.2 NaHCO<sub>3</sub>, 11.1 glucose, and 5 Hepes. Slices were allowed to recover for 45 min at room temperature before use.</p>
</sec>
<sec id="s3H">
<title>K<sup>+</sup>-sensitive microelectrodes</title>
<p>Borosilicate glass capillary tubes (Warner Instrument Corp.; GC200F-10; OD: 2.0 mm, ID: 1.16 mm) were washed in concentrated nitric acid, water, then 100% EtOH and dried overnight at 200°C. Pipettes were pulled on Sutter Instrument Model P-97 and then placed upright and incubated above a dish containing silane [bis(dimethylamino)dimethylsilane] for 5 min at 200°C. Using a fine-tipped syringe (Microfil 28 AWG, World Precision Instruments), a K<sup>+</sup> ion exchanger (IE190, World Precision Instruments) was filled at the pipette tip, with care taken to ensure no bubbles. Pipettes were then backfilled with 100 m<sc>m</sc> KCl. K<sup>+</sup>-sensitive microelectrodes were calibrated with solutions containing in m<sc>m</sc>: 133 NaCl, 3 KCl, 1.5 CaCl<sub>2</sub>, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, 1 MgCl<sub>2</sub>, 10 glucose, and 8.55 Hepes or 106 NaCl, 30 KCl, 1.5 CaCl<sub>2</sub>, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, 1 MgCl<sub>2</sub>, 10 glucose, and 8.55 Hepes after every experiment. All experiments were performed using a World Precision Instruments electrometer (model FD 223), digitized with a Digidata 1440A (Molecular Devices), and stored and analyzed using Clampex 10.2. K<sup>+</sup> responses were recorded, at depths 40–75 μm into the slice, in layer II/III of the cortex resulting from 3 consecutive 1-s stimulations of 100 μA at 20 Hz (0.1-μs pulse width) in layer IV/V of the cortex. Signals were low-pass filtered at 10 Hz.</p>
</sec>
<sec id="s3I">
<title>Whole-cell patch clamp electrophysiology</title>
<p>Patch pipettes were pulled from thin-walled borosilicate glass (World Precision Instruments, catalog no. TW150F-4) and filled with pipette solution containing the following in m<sc>m</sc>: 125 K-gluconate, 10 KCl, 10 Hepes (free acid), 10 disodium creatine phosphate, 2 MgATP, 0.2 NaGTP, and 0.5 EGTA. The pipette solution was brought to pH 7.3 with KOH and 285–290 mOsm with sucrose. After filling patch pipettes with pipette solution, final resistances were 6–8 MΩ. Slices were transferred to a Zeiss Examiner D1 equipped with a 40× water-immersion lens and Zeiss Axiocam MRm for imaging and constantly perfused with ∼30°C ACSF. Astrocytes were identified using morphologic features. Recordings were made with an Axopatch 200B amplifier (Molecular Devices), low-pass filtered at 1 kHz, and digitized with Digidata 1440A (Molecular Devices). Data were acquired and stored on a personal computer using Clampex 10.2. Cell capacitance and series resistance were compensated for using the amplifier. Cell capacitance was measured from the amplifier. Experiments with a series resistance up to 12 MΩ were used, and series resistance was compensated for by 80% to reduce voltage errors. Steady-state currents were measured.</p>
</sec>
<sec id="s3J">
<title>Chromatin immunoprecipitation</title>
<p>Half-brains from 7–9-wk-old <italic>Mecp2<sup>+/y</sup></italic> and <italic>Mecp2<sup>–/y</sup></italic> mice were collected for chromatin immunoprecipitation (ChIP) analysis. Chromatin preparation was performed using the Magna ChIP G Tissue Kit (Millipore) according to manufacturer’s instructions. Briefly, samples were sheared in 1× Tissue Stabilizing Solution (Millipore) with protease inhibitors using a 1-ml pipette tip. Samples were then fixed in 1% formaldehyde for 10 min at 37°C with minor agitation. The fixation was quenched using 10× glycine (for final concentration at 1×) and incubated for 5 min at room temperature. Cross-linked samples were washed 3 times in ice-cold 1× PBS with protease inhibitors. Samples were then lysed on ice in Tissue Lysis Buffer with protease inhibitors for 15 min, with brief vortexing every 5 min. Samples were resuspended in 600 µl ChIP Dilution Buffer with protease inhibitors and sonicated on wet ice under the following conditions: 10 s pulse, 50 s rest, 20% amplitude, 5 total cycles. After sonication, samples were centrifuged at 15,000 rcf at 4°C for 10 min. The resulting supernatant was collected and distributed into 200-µl aliquots for immunoprecipitation (IP).</p>
<p>IP, washes, reverse cross-linking, and DNA collection and purification were performed as outlined in <xref ref-type="bibr" rid="B36">Li et al. (2012)</xref> with the following modifications. (1) Additional ChIP Dilution Buffer with protease inhibitors was added to each aliquot for a final volume of 500 µl. (2) Both IPs and inputs were digested using 10 µl of 0.5 <sc>m</sc> EDTA, 20 µl of 1 <sc>m</sc> Tris, pH 6.5, and 1 µl of 20 mg/ml proteinase K (Clontech) for 1 h at 55°C with minor agitation. DNA was collected and purified using the Qiagen PCR Purification kit according to manufacturer’s instructions with the following modifications. (1) At the final elution step, EB buffer was incubated on the column for 10 min before centrifugation. 2) Final DNA was eluted in 50 µl. Quantitative PCR (qPCR) was performed on the Bio-Rad CFX96 machine using the Applied Biosystems SYBR Select Master Mix for CFX. qPCR cycling parameters were as follows: 95°C for 3 min, followed by 40 cycles of 95°C for 10 s, 60°C for 30 s, and 72°C for 45 s, and a final incubation at 70°C for 10 min. Primer efficiency was verified through melting-curve analysis (60°C for 1 min, and 0.5°C increments starting at 60°C up to 95°C for 15 s each) and running qPCR products on a 1.5% agarose gel. Primers used to amplify specific regions within <italic>Kcnj10</italic> promoter region are listed in <xref ref-type="table" rid="T1">Table 1</xref>. The ddCT method was used to determine fold change expression in <italic>Mecp2<sup>+/y</sup></italic> relative to <italic>Mecp2<sup>–/y</sup></italic> mice. Briefly, the ddCT was calculated as the following:<disp-formula id="E1"><mml:math id="m1"><mml:mrow><mml:mtext>dCT</mml:mtext><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mtext>CT</mml:mtext></mml:mrow><mml:mrow><mml:mtext>IP</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>MeCP2 or IgG</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msup><mml:mo>–</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mtext>CT</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Input</mml:mtext></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mtext>6</mml:mtext><mml:mo>.</mml:mo><mml:mtext>644</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
where 6.644 represents 1% starting input;<disp-formula id="E2"><mml:math id="m2"><mml:mrow><mml:mtext>ddCT</mml:mtext><mml:mo>=</mml:mo><mml:mtext>dCT</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>M</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>p</mml:mi><mml:msup><mml:mn>2</mml:mn><mml:mrow><mml:mo>+</mml:mo><mml:mo>/</mml:mo><mml:mi>y</mml:mi></mml:mrow></mml:msup><mml:mtext>or </mml:mtext><mml:mi>M</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>p</mml:mi><mml:msup><mml:mn>2</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mo>/</mml:mo><mml:mi>y</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>–</mml:mo><mml:msup><mml:mrow><mml:mtext>average MeCP2</mml:mtext></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mo>/</mml:mo><mml:mtext>Y</mml:mtext></mml:mrow></mml:msup><mml:mtext>dCT</mml:mtext><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula> Fold change expression was calculated using the formula 2<sup>–ddCT</sup> for both <italic>Mecp2<sup>+/y</sup></italic> and <italic>Mecp2<sup>–/y</sup></italic> mice.</p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>Targeted Kir4.1 CpG island I (promoter) PCR amplification sites</p>
</caption>
<table frame="hsides" rules="none">
<colgroup span="1">
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Target name</th>
<th align="left" colspan="1" rowspan="1">Forward primer sequence</th>
<th align="left" colspan="1" rowspan="1">Reverse primer sequence</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="1" rowspan="1">CpG I-1</td>
<td colspan="1" rowspan="1">5′-AGTTTCCCTGCTTTCAATCCTG-3′</td>
<td colspan="1" rowspan="1">5′-CCTGTGGGAACACAGACACA-3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CpG I-2</td>
<td colspan="1" rowspan="1">5′-GGATGGGAAGAGTTTGACGC-3′</td>
<td colspan="1" rowspan="1">5′-TACGGTGCAAAGTGTGGGAG-3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CpG I-3</td>
<td colspan="1" rowspan="1">5′-CACACTTTGCACCGTACTGC-3′</td>
<td colspan="1" rowspan="1">5′-GATAGAAGCCGAGCTGGCAA-3′</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CpG I-4</td>
<td colspan="1" rowspan="1">5′-GGCCGCCTCACTTTTCTTCT-3′</td>
<td colspan="1" rowspan="1">5′-TGGAGAGATTTGGGCAAGGC-3′</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3K">
<title>Data analysis</title>
<p>Data were organized in Microsoft Excel or Origin 8.5. Unless stated otherwise, two-tailed <italic>t</italic> tests were performed as appropriate, except for non–normally distributed data, in which case Mann–Whitney nonparametric test was performed. In <xref ref-type="fig" rid="F5">Fig. 5</xref>, two-way ANOVA was performed with Tukey <italic>post hoc</italic> comparison. The statistical tests were performed using InStat 3 (GraphPad Software) or MYSTAT (Systat Software). All data are reported as average ± SEM.</p>
</sec>
</sec>
<sec id="s4" sec-type="results">
<title>Results</title>
<sec id="s4A">
<title>Kir4.1 currents are significantly decreased in Mecp2<sup>–/y</sup> mice</title>
<p>Astrocytes contribute to symptomology of RTT (<xref ref-type="bibr" rid="B38">Lioy et al., 2011</xref>). However, few studies have examined the functional differences between WT and RTT astrocytes. Kir4.1, a glia-specific inward rectifying channel, is critical for normal CNS function. Mutations in <italic>KCNJ10</italic> have been linked to developmental disorders characterized by early onset seizures, ataxia, epilepsy, and profound developmental delay (<xref ref-type="bibr" rid="B33">Kofuji et al., 2000</xref>). Of note, these symptoms are also observed in RTT. We therefore sought to investigate the properties of Kir4.1 channel function and expression in RTT.</p>
<p>MeCP2 expression is high in cortical tissue and apparent cortical dysfunction is observed in <italic>Mecp2</italic>-deficient mice (<xref ref-type="bibr" rid="B31">Kishi and Macklis, 2004</xref>; <xref ref-type="bibr" rid="B16">D’Cruz et al., 2010</xref>). Kir4.1 currents were measured in layer I and layer II/III cortical astrocytes of symptomatic <italic>Mecp2</italic> mutant male (<italic>Mecp2<sup>–/y</sup></italic>) mice and littermate age- and sex-matched controls. To isolate Kir4.1 currents, we stepped cortical astrocytes from a holding potential of –80 to 0 mV, and then from –180 to 100 mV in 20-mV increments. We washed on 100 μM BaCl<sub>2</sub>, a concentration that specifically blocks Kir channels (<xref ref-type="bibr" rid="B55">Ransom and Sontheimer, 1995</xref>), and subtracted out currents that were sensitive to BaCl<sub>2</sub>. As there was no significant difference between astrocytes in layer I and layer II/III (data not shown), we pooled both layers together. Astrocyte recordings obtained from WT mice (<italic>n</italic> = 24) displayed large-amplitude, linear currents typical of passive astrocytes (<xref ref-type="bibr" rid="B72">Zhou et al., 2006</xref>). As depicted in <xref ref-type="fig" rid="F1">Fig. 1<italic>E</italic></xref>, the “passive” Ba<sup>2+</sup>-sensitive Kir4.1 currents were smaller in <italic>Mecp2<sup>–/y</sup></italic> astrocytes (<italic>n</italic> = 19). Although whole-cell currents were significantly smaller in <italic>Mecp2<sup>–/y</sup></italic> astrocytes (<xref ref-type="fig" rid="F1">Fig. 1<italic>C</italic></xref>), which could be partially explained by smaller Ba<sup>2+</sup>-sensitive Kir4.1 currents, there was also a decrease in other unidentified Ba<sup>2+</sup>-insensitive currents in <italic>Mecp2<sup>–/y</sup></italic> astrocytes (<xref ref-type="fig" rid="F1">Fig. 1<italic>D</italic></xref>). In an attempt to identify other K<sup>+</sup> channels disrupted in the cortex of MeCP2-deficient mice, we mined RNA sequencing data from a recent transcriptomic study performed in the cortex of WT and symptomatic MeCP2-deficient mice that were age matched with the current study. Of the 15 <italic>Kcnj</italic> genes identified in that RNA sequencing study, only <italic>Kcnj10</italic> (Kir4.1) and <italic>Kcnj16</italic> (Kir5.1, a channel thought to form heteromers with Kir4.1, but not homomeric channels) were significantly downregulated in the cortex of MeCP2-deficient mice (<xref ref-type="table" rid="T2">Table 2</xref>). Of the 14 <italic>Kcnk</italic> genes identified, only <italic>Kcnk2</italic> (Trek-1) was differentially expressed, and it was modestly upregulated. Together, these data suggest that a loss of Kir4.1 homomers and possibly Kir4.1/Kir5.1 heteromeric channels contribute to the reduced K<sup>+</sup> conductance observed in MeCP2-deficient mice.</p>
<fig fig-type="figure" id="F1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Ba<sup>2+</sup>-sensitive Kir4.1 currents are significantly reduced in layer II/III astrocytes of <italic>Mecp2<sup>–/y</sup></italic> mice. <bold><italic>A</italic></bold>, Representative traces of pre-Ba<sup>2+</sup>, post-Ba<sup>2+</sup>, and Ba<sup>2+</sup>-sensitive currents in WT and <italic>Mecp2<sup>–/y</sup></italic> astrocytes. <bold><italic>B</italic></bold>, <italic>Mecp2<sup>–/y</sup></italic> astrocytes show higher input resistance than their WT littermates. <bold><italic>C–E</italic></bold>, Current–voltage graphs (<italic>n</italic> = 19–24) demonstrate that pre-Ba<sup>2+</sup>, post-Ba<sup>2+</sup>, and Ba<sup>2+</sup>-sensitive currents are significantly reduced in <italic>Mecp2<sup>–/y</sup></italic> astrocytes [except at the –80-mV step in the pre-Ba<sup>2+</sup> currents (<bold><italic>C</italic></bold>) and the Ba<sup>2+</sup>-sensitive currents (<bold><italic>E</italic></bold>)]. In all, results are consistent with a reduction of Kir4.1 currents in the plasma membrane. Mann–Whitney test was conducted for each voltage step between the two genotypes. **, <italic>p</italic> &lt; 0.01.</p>
</caption>
<graphic xlink:href="enu0011825490001"></graphic>
</fig>
<table-wrap id="T2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption>
<p>RNA sequencing indicates 14 <italic>kcnj</italic> and 15 <italic>kcnk</italic> potassium channels identified in the cortex of symptomatic MeCP2<sup><sup>–/y</sup></sup> mice and WT age-matched littermates</p>
</caption>
<table frame="hsides" rules="none">
<colgroup span="1">
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Protein</th>
<th align="left" colspan="1" rowspan="1">Gene name</th>
<th align="left" colspan="1" rowspan="1">FPKM WT</th>
<th align="left" colspan="1" rowspan="1">FPKM TG</th>
<th align="left" colspan="1" rowspan="1">Fold change</th>
<th align="left" colspan="1" rowspan="1"><italic>q</italic> value</th>
<th align="left" colspan="1" rowspan="1">Cell type specificity</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="1" rowspan="1">Kir4.1</td>
<td colspan="1" rowspan="1">
<italic>Kcnj10</italic>
</td>
<td colspan="1" rowspan="1">80.991</td>
<td colspan="1" rowspan="1">65.281</td>
<td colspan="1" rowspan="1">–0.311</td>
<td colspan="1" rowspan="1">0.00065</td>
<td colspan="1" rowspan="1">Astrocytes/oligodendrocytes/OPCs</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Kir5.1</td>
<td colspan="1" rowspan="1">
<italic>Kcnj16</italic>
</td>
<td colspan="1" rowspan="1">14.832</td>
<td colspan="1" rowspan="1">11.353</td>
<td colspan="1" rowspan="1">–0.386</td>
<td colspan="1" rowspan="1">0.00853</td>
<td colspan="1" rowspan="1">Astrocytes/OPCs</td>
</tr>
<tr>
<td colspan="1" rowspan="1">TREK-1</td>
<td colspan="1" rowspan="1">
<italic>Kcnk2</italic>
</td>
<td colspan="1" rowspan="1">25.299</td>
<td colspan="1" rowspan="1">31.559</td>
<td colspan="1" rowspan="1">0.319</td>
<td colspan="1" rowspan="1">0.03503</td>
<td colspan="1" rowspan="1">Astrocytes/neurons/OPCs</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF1">
<p>Only <italic>Kcnj10</italic>, <italic>Kcnj16</italic> and <italic>Kcnk2</italic> are differentially expressed (data mined from Pacheco et al., 2017).
</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Kir4.1 channels contribute to the intrinsic membrane properties of astrocytes (<xref ref-type="bibr" rid="B33">Kofuji et al., 2000</xref>; <xref ref-type="bibr" rid="B15">D’Ambrosio et al., 2002</xref>; <xref ref-type="bibr" rid="B48">Neusch et al., 2006</xref>; <xref ref-type="bibr" rid="B52">Olsen et al., 2006</xref>; <xref ref-type="bibr" rid="B20">Djukic et al., 2007</xref>; <xref ref-type="bibr" rid="B11">Chever et al., 2010</xref>; <xref ref-type="bibr" rid="B41">Ma et al., 2014</xref>). Therefore, we examined input resistance and resting membrane potential (RMP) in WT and <italic>Mecp2<sup>–/y</sup></italic> cortical astrocytes. Kir4.1 has a high open probability at rest (<xref ref-type="bibr" rid="B50">Nwaobi et al., 2016</xref>), and the relative expression levels of Kir4.1 correlate with the astrocyte input resistance. Lower Kir4.1 channel activity in <italic>Mecp2<sup>–/y</sup></italic> mice was associated with significantly higher membrane resistance (<xref ref-type="fig" rid="F1">Fig. 1<italic>B</italic></xref>; 15.9 ± 2.8 MΩ in WT vs. 33.2 ± 5.6 MΩ in <italic>Mecp2<sup>–/y</sup></italic>; <italic>p</italic> = 0.006; <italic>n</italic> = 19–23). However, both genotypes showed similar hyperpolarized resting membrane potential (–77.9 ± 0.7 mV in WT vs. –76.6 ± 0.9 mV in <italic>Mecp2<sup>–/y</sup></italic>; <italic>p</italic> = 0.23; <italic>n</italic> = 19–24) and whole-cell capacitance, a measure of cell size (18.5 ± 1.5 pF in WT vs. 20.3 ± 2.9 pF in <italic>Mecp2<sup>–/y</sup></italic>; <italic>p</italic> = 0.56; <italic>n</italic> = 19–24). The lack of a change in RMP is in contrast to previous reports regarding the importance of Kir4.1 to the RMP of astrocytes (<xref ref-type="bibr" rid="B52">Olsen et al., 2006</xref>; <xref ref-type="bibr" rid="B20">Djukic et al., 2007</xref>; <xref ref-type="bibr" rid="B59">Seifert et al., 2009</xref>). The lack of a change in resting membrane potential in RTT astrocytes may be explained by the partial reduction in current in <italic>Mecp2<sup>–/y</sup></italic> mice as opposed to complete knockout (Kir4.1 KO mice) or knockdown (siRNA knockdown in cultured astrocytes) as published in previous reports. Astrocytes are thought to be selectively permeable to K<sup>+</sup> ions; as such, the remaining Kir4.1 and leak channels would maintain the resting membrane potential near the K<sup>+</sup> equilibrium potential. Alternatively, the increased <italic>Kcnk2</italic> gene expression in the cortex of MeCP2<sup>–/y</sup> mice may compensate for lower levels of Kir4.1 expression.</p>
</sec>
<sec id="s4B">
<title>[K<sup>+</sup>]<sub>o</sub> homeostasis is dysregulated in MeCP2<sup>–/y</sup> mice</title>
<p>Given the previously demonstrated role of astrocytes in the buffering and maintenance of [K<sup>+</sup>]<sub>o</sub> (<xref ref-type="bibr" rid="B32">Kofuji and Newman, 2004</xref>), we assessed whether K<sup>+</sup> homeostasis is disrupted in <italic>Mecp2<sup>–/y</sup></italic> mice. To test this, we stimulated neuronal activity in layer IV/V of the cortex with a 1-s stimulus (20 Hz, 100 μA) followed by a 30-s recovery, performed 3 times in series. Changes in [K<sup>+</sup>]<sub>o</sub> were measured in layer II/III with a calibrated K<sup>+</sup>-sensitive microelectrode. Upon insertion of the K<sup>+</sup>-sensitive microelectrode into the slice, we detected a spike in [K<sup>+</sup>]<sub>o</sub> followed by a fall to a steady-state level. Consistent with the possibly that MeCP2 regulates Kir4.1 expression and consequentially K<sup>+</sup> homeostasis, we found the peak of this K<sup>+</sup> spike to be larger in <italic>Mecp2<sup>–/y</sup></italic> mice compared with WT littermates (5.2 ± 0.5 m<sc>m</sc> in WT vs. 7.9 ± 1.2 in <italic>Mecp2<sup>–/y</sup></italic>; <xref ref-type="fig" rid="F2">Fig. 2<italic>B</italic></xref>, left; <italic>p</italic> &lt; 0.05; <italic>n</italic> = 7–8). Additionally, steady-state [K<sup>+</sup>]<sub>o</sub> was higher in <italic>Mecp2<sup>–/y</sup></italic> mice compared with WT littermates (4.2 ± 0.2 m<sc>m</sc> in WT vs. 5.1 ± 0.4 in <italic>Mecp2<sup>–/y</sup></italic>; <xref ref-type="fig" rid="F2">Fig. 2<italic>A</italic></xref>, dashed line, <xref ref-type="fig" rid="F2">Fig. 2<italic>B</italic></xref>, middle; <italic>p</italic> &lt; 0.05; <italic>n</italic> = 7–8). Intriguingly, a similar elevation in baseline K<sup>+</sup> was observed in a murine model of Huntington disease, which showed similar reductions in astrocyte Kir4.1-mediated currents (<xref ref-type="bibr" rid="B63">Tong et al., 2014</xref>). We also observed an increase in the amplitude of the K<sup>+</sup> undershoot after the second stimulation (<xref ref-type="fig" rid="F2">Fig. 2<italic>A</italic></xref>, arrows). The amplitude of the undershoot under baseline increased from 0.03 ± 0.02 m<sc>m</sc> in WT to 0.08 ± 0.02 m<sc>m</sc> in MeCP2<sup>–/y</sup> mice (<xref ref-type="fig" rid="F2">Fig. 2<italic>B</italic></xref>, right; <italic>p</italic> &lt; 0.05; <italic>n</italic> = 6–9). Using a similar approach, Chever et al. (2010) demonstrated the appearance of a significant undershoot after stimulation in the hippocampus of GFAP-targeted Kir4.1 knockout mice. Together, these data indicate that K<sup>+</sup> homeostasis is disrupted in MeCP2<sup>–/y</sup> mice and support the possibility that loss of MeCP2 disrupts Kir4.1 function.</p>
<fig fig-type="figure" id="F2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p>[K<sup>+</sup>]<sub>o</sub> is elevated and [K<sup>+</sup>]<sub>o</sub> undershoots after stimulation in MeCP2<sup>–/y</sup> cortex. <bold><italic>A</italic></bold>, Representative changes in [K<sup>+</sup>]<sub>o</sub> after three successive stimulations in WT and <italic>Mecp2<sup>–/y</sup></italic> slices. Baseline [K<sup>+</sup>]<sub>o</sub> (dashed horizontal line) is elevated in <italic>Mecp2<sup>–/y</sup></italic> slices. <bold><italic>B</italic></bold>, Left, peak [K<sup>+</sup>]<sub>o</sub> increase after insertion of K<sup>+</sup>-sensitive microelectrode into slice is greater in <italic>Mecp2<sup>–/y</sup></italic> slices. Middle, steady-state [K<sup>+</sup>]<sub>o</sub> is elevated in <italic>Mecp2<sup>–/y</sup></italic> slices. Right, K<sup>+</sup> undershoot after the second stimulation is greater in <italic>Mecp2<sup>–/y</sup></italic> slices. *, <italic>p</italic> &lt; 0.05.</p>
</caption>
<graphic xlink:href="enu0011825490002"></graphic>
</fig>
</sec>
<sec id="s4C">
<title>Kir4.1 protein expression is significantly downregulated in Mecp2<sup>–/y</sup> mice</title>
<p>To investigate whether decrease in currents stems from decreased Kir4.1 protein expression, we examined Kir4.1 expression in the cortex. We isolated the cortex through microdissection, and Western blot analysis revealed 63% downregulation of Kir4.1 protein expression in <italic>Mecp2<sup>–/y</sup></italic> mice compared with littermate controls, with GAPDH and tubulin used as loading controls (<xref ref-type="fig" rid="F3">Fig. 3<italic>A</italic>, <italic>B</italic></xref>; <italic>p</italic> &lt; 0.05; <italic>n</italic> = 10–12). The bands on the Western blot represent both tetrameric (∼150-kDa) and monomeric (∼50-kDa) isoforms of Kir4.1 (<xref ref-type="fig" rid="F3">Fig. 3<italic>A</italic></xref>), which are commonly observed when blotting for Kir4.1 and are not observed in negative control samples (HEK cells or Kir4.1 KO mice; <xref ref-type="bibr" rid="B52">Olsen et al., 2006</xref>). Intriguingly, higher multimers of Kir4.1 are associated with developmental upregulation of the channel that occurs during postnatal development and astrocytic maturation (Dibaj et al., 2007), and these higher molecular weight bands are reduced in MeCP2-deficient mice.</p>
<fig fig-type="figure" id="F3" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<p>Kir4.1 protein is downregulated in <italic>Mecp2<sup>–/y</sup></italic> brains. <bold><italic>A</italic></bold>, Representative Western blot of cortical protein lysates from 5 wild-type and 6 symptomatic <italic>Mecp2<sup>–/y</sup></italic> males demonstrates a significant loss of Kir4.1 protein expression in cortex (∼150 kDa tetramer, 37 kDa monomer) when normalized to a loading control (GAPDH or tubulin). <bold><italic>B</italic></bold>, Quantification of ImageJ analysis normalizing Kir4.1 protein expression to GAPDH in cortex. Similar loss of Kir4.1 immunoreactivity in <italic>Mecp2</italic>-deficient male mice is seen in brainstem and hippocampus. In isolated astrocytes, Kir4.1 expression is lower in <italic>Mecp2<sup>–/y</sup></italic> mice compared to WT, as in whole-cortex lysate (<bold><italic>C</italic></bold>, <bold><italic>D</italic></bold>).</p>
</caption>
<graphic xlink:href="enu0011825490003"></graphic>
</fig>
<p>We have recently shown that Kir4.1 is expressed at significantly higher levels in the brainstem relative to other CNS structures (<xref ref-type="bibr" rid="B49">Nwaobi et al., 2014</xref>). Therefore, we also examined whole-brainstem homogenates from WT and <italic>Mecp2<sup>–/y</sup></italic> to determine whether Kir4.1 was affected in this structure. Western blots indicate a 20% downregulation of Kir4.1 in the brainstem (<xref ref-type="fig" rid="F3">Fig. 3<italic>B</italic></xref>; <italic>p</italic> &lt; 0.05; <italic>n</italic> = 9–12). Given that a deficiency of Kir4.1 may also contribute to hyperexcitability in the hippocampus (<xref ref-type="bibr" rid="B8">Calfa et al., 2011b</xref>), we probed for Kir4.1 expression and found a 36% downregulation (<xref ref-type="fig" rid="F3">Fig. 3<italic>B</italic></xref>; <italic>p</italic> &lt; 0.05; <italic>n</italic> = 6–7). Loss of Kir4.1 in cortex, brainstem, and hippocampus may contribute to altered function in these brain regions in <italic>Mecp2<sup>–/y</sup></italic> mice.</p>
<p>Kir4.1 is most highly expressed in astrocytes but is also expressed in oligodendrocytes and NG2<sup>+</sup> glia (<xref ref-type="bibr" rid="B50">Nwaobi et al., 2016</xref>). To evaluate Kir4.1 expression in WT and <italic>Mecp2<sup>–/y</sup></italic> in astrocytes specifically, versus a whole-cortical homogenate, magnetic cell separation (MACS) was used (<xref ref-type="bibr" rid="B26">Holt and Olsen, 2016</xref>). Astrocytes were isolated from symptomatic MeCP2-deficient males and their age-matched littermates. Western blot analysis from isolated astrocytes in WT and Mecp2-deficient mice indicated that Kir4.1 is significantly decreased (<xref ref-type="fig" rid="F3">Fig. 3<italic>C</italic>, <italic>D</italic></xref>; <italic>p</italic> &lt; 0.01). The reduction is similar in both whole cortex and isolated astrocytes (<xref ref-type="fig" rid="F3">Fig. 3<italic>D</italic></xref>).</p>
</sec>
<sec id="s4D">
<title>Kir4.1 (Kcnj10) RNA expression is significantly downregulated in Mecp2<sup>–/y</sup> and Mecp2<sup>–/+</sup> mice</title>
<p>As we demonstrated a global decrease in expression of Kir4.1 protein in <italic>Mecp2</italic>-deficient mice (<xref ref-type="fig" rid="F3">Fig. 3</xref>), we next examined whether <italic>Kcnj10</italic> transcription is altered in the RTT brain. As a first step, we performed quantitative PCR (qPCR) on microdissected samples isolated from symptomatic <italic>Mecp2<sup>–/y</sup></italic> mice and WT littermates to examine <italic>Kcnj10</italic> gene expression. In all brain regions, there was a significant loss of <italic>Kcnj10</italic> transcription (<xref ref-type="fig" rid="F4">Fig. 4<italic>A</italic></xref>): midbrain (41 ± 15%, <italic>p</italic> &lt; 0.05) cerebellum (32 ± 3%, <italic>p</italic> &lt; 0.001), brainstem (31 ± 5%, <italic>p</italic> &lt; 0.001), cortex (31 ± 5%, <italic>p</italic> &lt; 0.001), and hippocampus (18 ± 8%, <italic>p</italic> &lt; 0.05). Additionally, MACS-isolated astrocytes from P60 symptomatic <italic>Mecp2<sup>–/y</sup></italic> mice cortex also showed reduction in <italic>Kcnj10</italic> transcription, same as in the whole brain (<xref ref-type="fig" rid="F4">Fig. 4<italic>B</italic></xref>, 33 ± 25%, <italic>p</italic> &lt; 0.05).</p>
<fig fig-type="figure" id="F4" orientation="portrait" position="float">
<label>Figure 4.</label>
<caption>
<p>Decreased Kir4.1 transcription in <italic>Mecp2</italic>-deficient mice. <bold><italic>A</italic></bold>, <italic>Kcnj10</italic> mRNA is significantly downregulated in microdissected cerebellum, midbrain, cortex, hippocampus, and brainstem of <italic>Mecp2<sup>–/y</sup></italic> mice. <bold><italic>B</italic></bold>, Similar reduction is observed in isolated cortical astrocytes from <italic>Mecp2<sup>–/y</sup></italic> mice. <bold><italic>C</italic></bold>, <bold><italic>D</italic></bold>, <italic>Kcnj10</italic> is significantly downregulated in the cortex and brainstem of <italic>Mecp2</italic>± symptomatic female mice. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic xlink:href="enu0011825490004"></graphic>
</fig>
<p>Most research involving murine models of RTT involve mutant male mice, although RTT typically affects females. Female mice present a slightly less severe and more heterogeneous symptomology that has a delayed onset, due to variable X-chromosome inactivation (<xref ref-type="bibr" rid="B7">Calfa et al., 2011a</xref>). The mutation in our mice, the Jaenisch mutation, expresses in half of the neurons, except at 9-mo-old females in the dentate gyrus, which tend to express less (∼40%) of the chromosome with the mutation (<xref ref-type="bibr" rid="B62">Smrt et al., 2011</xref>). Nonetheless, there is no data concerning the effect of X-linked inactivation in glial cells. However, because RTT typically affects females, we asked whether loss of MeCP2 function is also associated with decreased <italic>Kcnj10</italic> mRNA expression in <italic>Mecp2</italic><sup>±</sup> mice. Symptomatic <italic>Mecp2</italic><sup>±</sup> mice (7–8 mo of age), which displayed motor abnormalities including hindlimb clasping, were used for these studies. We observed a significant decrease in <italic>Kcnj10</italic> gene expression in <italic>Mecp2</italic><sup>±</sup> symptomatic females in the cortex (<xref ref-type="fig" rid="F4">Fig. 4<italic>C</italic></xref>, 1.01 ± 0.08 WT vs. 0.61 ± 0.07 <italic>Mecp2</italic><sup>±</sup>) and brainstem (<xref ref-type="fig" rid="F4">Fig. 4<italic>D</italic></xref>, 1.01 ± .07 WT vs. 0.67 ± 0.11 MeCP2<sup>±</sup>). Interestingly, the decrease in mRNA in female <italic>Mecp2</italic><sup>±</sup> mice was significantly larger than that seen in males, although females presumably maintain ∼50% MeCP2 expression. The decrease in <italic>Kcnj10</italic> mRNA expression suggests a transcriptional mechanism of regulation.</p>
</sec>
<sec id="s4E">
<title>MeCP2 regulates Kcnj10 transcription in a cell-autonomous mechanism</title>
<p>The question remains whether MeCP2 controls <italic>Kcnj10</italic> expression via a cell-autonomous mechanism (i.e., direct effect of MeCP2 in astrocytes) or via an indirect effect. To attempt to discern between the two possibilities, we used neuronal-free primary cultured astrocytes. Cortical astrocytes from either WT or <italic>Mecp2<sup>–/y</sup></italic> P3 mice pups (<italic>n</italic> = 8–12 samples, with 4–6 total cultures, 2 biological replicates per culture) were isolated using the MACS astrocyte isolation as described previously. These astrocytes were cultured for either 7 or 14 DIV, when cells were collected and RNA transcription was measured using qPCR. The cultured astrocytes retained their shaped as assessed by GFAP staining (<xref ref-type="fig" rid="F5">Fig. 5<italic>A</italic></xref>), and the RNA expression profile fitted that of isolated astrocytes: <italic>Gfap</italic> and <italic>Kcnj10</italic> expression matching whole-cortex expression, whereas markers for other cell types were depleted (<xref ref-type="fig" rid="F5">Fig. 5<italic>B</italic></xref>). We observed no difference in <italic>Kcnj10</italic> transcription between the two genotypes at 7 DIV (<xref ref-type="fig" rid="F5">Fig. 5</xref>, <italic>p</italic> = 0.98), when <italic>Kcnj10</italic> transcription levels <italic>in situ</italic> are also relatively low. In contrast, <italic>Kcnj10</italic> transcription increases significantly in WT astrocytes after 14 DIV, indicative of normal developmental upregulation (<xref ref-type="fig" rid="F5">Fig. 5</xref>, <italic>p</italic> &lt; 0.001). Transcription in <italic>Mecp2<sup>–/y</sup></italic> astrocytes did not increase (<italic>p</italic> = 0.99) and was significantly reduced compared with WT astrocytes (<italic>p</italic> &lt; 0.01). These data suggest that loss of <italic>Kcnj10</italic> transcription is autonomous to the mutant astrocyte and results from loss of astrocytic <italic>MeCP2</italic>.</p>
<fig fig-type="figure" id="F5" orientation="portrait" position="float">
<label>Figure 5.</label>
<caption>
<p>Loss of <italic>Kcnj10</italic> is autonomous to astrocytes. With a magnetic-bead sorting technique, isolated astrocytes were plated and kept in serum-free medium for 7–14 d. Four to six cultures were used, with two biological replicates per culture, a total of 8–12 samples. <bold><italic>A</italic></bold>, By 7 d, WT astrocytes attain a stellate morphology as indicated by GFAP staining. <bold><italic>B</italic></bold>, By 14 d in culture astrocytes, <italic>Gfap</italic> and <italic>Kcnj10</italic> expression is enriched compared to age-matched cortex. Cultures express low levels of mRNA for other cell types including microglia (HexB, Tmem119), oligodendrocytes (Mbp), and neurons (Rbfox3), indicating relative purity of the astrocyte cultures. <bold><italic>C</italic></bold>, When examining the transcription of <italic>Kcnj10</italic>, there is a significant effect for both genotype (<italic>p</italic> &lt; 0.001) and DIV (<italic>p</italic> &lt; 0.001). There was no difference at 7 DIV between WT and <italic>Mecp2<sup>–/y</sup></italic> astrocytes in transcription of <italic>Kcnj10</italic>. Transcription of <italic>Kcnj10</italic> shows a typical developmental increase in WT astrocytes at 14 DIV, while such an increase was not seen with the <italic>Mecp2<sup>–/y</sup></italic> astrocytes. Two-way ANOVA was performed with Tukey <italic>post hoc</italic> comparison. *, <italic>p</italic> &lt; 0.05; ***, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic xlink:href="enu0011825490005"></graphic>
</fig>
</sec>
<sec id="s4F">
<title>Kir4.1 is a direct molecular target of MeCP2</title>
<p>Previous work has demonstrated that <italic>Kcnj10</italic> gene expression is robustly, developmentally up-regulated and dependent on the degree of methylation at its promoter (<xref ref-type="bibr" rid="B49">Nwaobi et al., 2014</xref>). We postulated that decreased <italic>Kcnj10</italic> transcription might be due to a loss of interaction between MeCP2 and the <italic>Kcnj10</italic> gene in <italic>Mecp2</italic>-deficient mice. To test this, we performed a chromatin immunoprecipitation (ChIP) assay. MeCP2 binds DNA in cytosine-phosphodiester-guanine (CpG) islands that are either methylated or unmethylated to modulate gene expression (<xref ref-type="bibr" rid="B9">Chahrour et al., 2008</xref>). To determine whether the entire <italic>Kcnj10</italic> gene contained CpG islands, we performed an <italic>in silico</italic> analysis of mouse <italic>Kcnj10</italic> gene (<xref ref-type="fig" rid="F6">Fig. 6<italic>A</italic></xref>). Two CpG islands were identified: the first spanned the promoter region and the 5′ UTR, and the second spanned the transcriptional start site and the initial segment of the exonic region. Because MeCP2 is often bound to actively transcribed promoters (<xref ref-type="bibr" rid="B67">Yasui et al., 2007</xref>), we designed four (100–150-bp) overlapping primers to amplify the promoter of <italic>Kcnj10</italic> (<xref ref-type="table" rid="T1">Table 1</xref>). The ChIP analysis was performed by probing for a MeCP2 protein interaction with regions 1–4 in the <italic>Kcnj10</italic> promoter. For these experiments, IgG served as a negative control, and RNA polymerase II (RNA Pol II) served as a positive control. Results from these experiments show significant interactions between MeCP2 and sites 1, 2, and 4 of <italic>Kcnj10</italic> in WT mice (<xref ref-type="fig" rid="F6">Fig. 6<italic>B</italic></xref>). To confirm the specificity of the immunoprecipitation, we performed the ChIP assay with <italic>Mecp2<sup>–/y</sup></italic> and did not detect any amplification (<xref ref-type="fig" rid="F6">Fig. 6<italic>C</italic></xref>). These data are the first demonstrating a direct molecular interaction between MeCP2 and an astrocyte gene target, providing possible mechanistic support for the loss of <italic>Kcnj10</italic> mRNA and its subsequent protein product in <italic>Mecp2</italic>-deficient mice.</p>
<fig fig-type="figure" id="F6" orientation="portrait" position="float">
<label>Figure 6.</label>
<caption>
<p><italic>Kcnj10</italic> is a direct molecular target of MeCP2. <bold><italic>A</italic></bold>, A schematic of the mouse <italic>Kcnj10</italic> gene indicating the promoter, 5′ UTR, intronic, and exonic region of the gene. The relative locations of primers used to query MeCP2 binding are indicated. <bold><italic>B</italic></bold>, <bold><italic>C</italic></bold>, ChIP results indicate significant physical interaction between MeCP2 and <italic>Kcnj10</italic> in three sites in the promoter of the <italic>Kcnj10</italic> gene (<bold><italic>B</italic></bold>, sites 1, 2, and 4, <italic>p</italic> &lt; 0.05, <italic>n</italic> = 5), while no interactions are found in the <italic>Mecp2</italic>-null mice (<bold><italic>C</italic></bold>). *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; #, <italic>p</italic> &lt; 0.0005; ##, <italic>p</italic> &lt; 0.0001.</p>
</caption>
<graphic xlink:href="enu0011825490006"></graphic>
</fig>
</sec>
<sec id="s4G">
<title>Kir4.1 gene and protein expression are downregulated early in disease progression in MeCP2<sup>–/y</sup> mice</title>
<p>Kir4.1 protein levels are markedly increased during early postnatal development, correlating with increased gene transcription and reduced methylation levels of the <italic>Kcnj10</italic> gene (<xref ref-type="bibr" rid="B49">Nwaobi et al., 2014</xref>). The most significant increases in gene and protein expression occur from in postnatal wk 2–4 (<xref ref-type="bibr" rid="B49">Nwaobi et al., 2014</xref>), when astrocytes undergo significant morphological refinement and maturation (<xref ref-type="bibr" rid="B6">Bushong et al., 2004</xref>). To determine whether MeCP2 deficiency altered normal developmental patterns of <italic>Kcnj10</italic> gene expression, we performed qPCR at two developmental time points (P10 and P21), which are early in the disease progression in RTT mice. No difference in <italic>Kcnj10</italic> transcription was observed at P10 (<xref ref-type="fig" rid="F7">Fig. 7<italic>A</italic></xref>), but we observed a ∼30% decrease in transcription in the <italic>Mecp2<sup>–/y</sup></italic> mice by P21 (<xref ref-type="fig" rid="F7">Fig. 7<italic>B</italic></xref>; <italic>p</italic> &lt; 0.05; <italic>n</italic> = 6). Western blot analysis indicates a significant deficit in Kir4.1 protein levels in <italic>Mecp2<sup>–/y</sup></italic> (<xref ref-type="fig" rid="F7">Fig. 7<italic>C</italic>, <italic>D</italic></xref>; <italic>p</italic> &lt; 0.05; <italic>n</italic> = 6) at both time points. These data demonstrate that normal protein levels of Kir4.1 are not achieved at any time point in <italic>Mecp2</italic>-deficient animals, which may be the result of a direct positive interaction between MeCP2 protein and <italic>Kcnj10</italic> gene promoter that is absent in MeCP2<sup>–/y</sup> mice.</p>
<fig fig-type="figure" id="F7" orientation="portrait" position="float">
<label>Figure 7.</label>
<caption>
<p>Kir4.1 is not sufficiently upregulated through development in <italic>Mecp2</italic>-deficient mice. <bold><italic>A</italic></bold>, <italic>Kcnj10</italic> mRNA is not significantly different in the cortex of p10 <italic>Mecp2<sup>–/y</sup></italic> mice. <bold><italic>B</italic></bold>, <italic>Kcnj10</italic> mRNA is significantly decreased in the cortex of p21 <italic>Mecp2<sup>–/y</sup></italic> mice. <bold><italic>C</italic></bold>, <bold><italic>D</italic></bold>, Representative Western blots and ImageJ quantification demonstrate loss of Kir4.1 protein expression in cortex in both p10 (<bold><italic>C</italic></bold>) and p21 (<bold><italic>D</italic></bold>) mice when normalized to a loading control (GAPDH). *, <italic>p</italic> &lt; 0.05.</p>
</caption>
<graphic xlink:href="enu0011825490007"></graphic>
</fig>
</sec>
</sec>
<sec id="s5" sec-type="discussion">
<title>Discussion</title>
<p>Several recent reports have implicated a role of glia in the progression of RTT (<xref ref-type="bibr" rid="B2">Ballas et al., 2009</xref>; <xref ref-type="bibr" rid="B42">Maezawa and Jin, 2010</xref>; <xref ref-type="bibr" rid="B38">Lioy et al., 2011</xref>; <xref ref-type="bibr" rid="B19">Derecki et al., 2012</xref>). Mechanistically, it was hypothesized that RTT astrocytes inhibited neuronal maturation through release of a molecule that stunted dendritic maturity or through deficient release of pro-growth soluble molecule. Previous <italic>in vitro</italic> work also suggests that excess glutamate contributes to abnormal neuronal morphology (<xref ref-type="bibr" rid="B42">Maezawa and Jin, 2010</xref>). In the current study, we demonstrate reduced Kir4.1 channel activity in cortical astrocytes. This decrease in channel activity is associated with significant reductions in Kir4.1 protein and mRNA levels and may result from the loss of a direct positive interaction between the MeCP2 protein and the <italic>Kcnj10</italic> gene promoter in MeCP2 knockout mice. Supporting this notion, astrocyte cultures derived from MeCP2<sup>–/y</sup> mice fail to upregulate Kir4.1 compared with cultures derived from WT mice. These results indicate that the loss of Kir4.1 is autonomous to the astrocyte and provide a mechanism for failure of Kir4.1 developmental upregulation in RTT mice. These data suggest that MeCP2 is a positive regulator of <italic>Kcnj10</italic> gene expression through development and potentially provide insight into how astrocytic dysfunction may contribute to RTT.</p>
<sec id="s5A">
<title>The role of Kir4.1 in RTT and normal brain</title>
<p>Accumulating evidence indicates that Kir4.1 plays an integral role in the CNS. Decreased Kir4.1 currents are associated with various pathologies such as epilepsy, cerebral trauma, cerebral ischemia, cerebral inflammation, Alzheimer’s disease, amyotrophic lateral sclerosis, and Huntington’s disease (<xref ref-type="bibr" rid="B50">Nwaobi et al., 2016</xref>). Here, we demonstrate that astrocyte Kir4.1 currents are significantly reduced in symptomatic MeCP2-deficient mice. Of note, the extent to which astrocytes are clamped is uncertain because of the leaky membrane and the complex morphology. Reduction in Kir4.1 function may contribute to neuronal dysfunction. After firing of an action potential, K<sup>+</sup> is extruded from neurons. Because of the small size of the extracellular space, small fluxes in K<sup>+</sup> can lead to large concentration changes that are sufficient to modulate the efficacy of neuronal transmission (<xref ref-type="bibr" rid="B56">Ransom et al., 2000</xref>). Regulation of extracellular potassium ([K<sup>+</sup>]<sub>o</sub>) is the most well-recognized function of astrocytes (<xref ref-type="bibr" rid="B35">Kuffler and Potter, 1964</xref>; <xref ref-type="bibr" rid="B53">Orkand et al., 1966</xref>; <xref ref-type="bibr" rid="B34">Kuffler, 1967</xref>; <xref ref-type="bibr" rid="B32">Kofuji and Newman, 2004</xref>). Basal [K<sup>+</sup>]<sub>o</sub> in rat hippocampal slices was increased when Kir channels were blocked with BaCl<sub>2</sub> (<xref ref-type="bibr" rid="B15">D’Ambrosio et al., 2002</xref>). Loss of Kir4.1, with a similar increase in [K<sup>+</sup>]<sub>o</sub>, was reported in a mouse model of Huntington’s disease (<xref ref-type="bibr" rid="B63">Tong et al., 2014</xref>) and is associated with medium spiny neuron dysfunction. AAV-mediated rescue of Kir4.1 specifically to astrocytes rescued elevated K<sup>+</sup>, prolonged survival, and ameliorated motor deficits in these mice.</p>
<p>Our data demonstrate that loss of Kir4.1 in MeCP2-deficient mice is associated with an increase in [K<sup>+</sup>]<sub>o</sub> and K<sup>+</sup> undershoot (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Inhibition of Kir4.1 with 200 μM barium in rat hippocampus led to elevated [K<sup>+</sup>]<sub>o</sub> and K<sup>+</sup> undershoot (<xref ref-type="bibr" rid="B15">D’Ambrosio et al., 2002</xref>), as in our work. The undershoot under normal conditions is explained by a model in which Kir4.1 maintains [K<sup>+</sup>]<sub>o</sub> by efflux of K<sup>+</sup> from astrocytes to balance excessive K<sup>+</sup> uptake by the ATPase (<xref ref-type="bibr" rid="B15">D’Ambrosio et al., 2002</xref>). Thus, loss of Kir4.1 leads to a larger K<sup>+</sup> undershoot and perturbation of [K<sup>+</sup>]<sub>o</sub>.</p>
<p>Given the role that Kir channels play in the regulation of K<sup>+</sup> concentration, loss of Kir4.1 in RTT may predict a change in neuronal excitability. There are conflicting reports regarding the excitability levels in the <italic>Mecp2</italic>-mutant brains. Some studies show hyperexcitability in various regions of mutant <italic>Mecp2</italic> mice from the level of the neuron (<xref ref-type="bibr" rid="B70">Zhang et al., 2010</xref>; <xref ref-type="bibr" rid="B8">Calfa et al., 2011b</xref>) up to the level of the neuronal network (<xref ref-type="bibr" rid="B1">Asaka et al., 2006</xref>; <xref ref-type="bibr" rid="B45">Moretti et al., 2006</xref>; <xref ref-type="bibr" rid="B69">Zhang et al., 2008</xref>; <xref ref-type="bibr" rid="B16">D’Cruz et al., 2010</xref>; <xref ref-type="bibr" rid="B8">Calfa et al., 2011b</xref>; <xref ref-type="bibr" rid="B13">Colic et al., 2011</xref>; <xref ref-type="bibr" rid="B44">McLeod et al., 2013</xref>). Other studies have not demonstrated the same hyperexcitability in RTT (<xref ref-type="bibr" rid="B18">Dani et al., 2005</xref>; <xref ref-type="bibr" rid="B17">Dani and Nelson, 2009</xref>; <xref ref-type="bibr" rid="B66">Wood et al., 2009</xref>). These discordant findings may be a result of examination at different stages of disease development. Studies reporting measurements from presymptomatic to early symptomatic animals (P14–P35) show hypoactivity, while studies demonstrating network hyperexcitability use tissue from older mice, which clearly exhibit symptoms associated with RTT (<xref ref-type="bibr" rid="B16">D’Cruz et al., 2010</xref>; <xref ref-type="bibr" rid="B13">Colic et al., 2011</xref>). Thus, excitability of cortical neurons may dramatically change during disease progression. Supporting this, measurements of cellular density in cortical layers II/III, IV, V, and VI in <italic>Mecp2<sup>–/y</sup></italic> mice demonstrate that no abnormalities are observed at P14, but by P56 changes in all cortical layers are apparent (<xref ref-type="bibr" rid="B31">Kishi and Macklis, 2004</xref>). This fits the findings in this study, in which Kir4.1 expression is normal in early development, and thus [K<sup>+</sup>] regulation by astrocytes may not be disrupted. Failure to upregulate Kir4.1 expression in astrocytes may contribute to the hyperexcitability in aged, symptomatic animals.</p>
<p>Supporting the importance of Kir4.1 in normal brain function, patient populations who carry loss-of-function mutations in the <italic>Kcnj10</italic> gene have been identified. Intriguingly, CNS symptoms in these patients, including early-onset seizures, ataxia, profound lower motor extremity weakness, and severe cognitive deficits (<xref ref-type="bibr" rid="B58">Scholl et al., 2009</xref>; <xref ref-type="bibr" rid="B60">Sicca et al., 2011</xref>), are also commonplace in RTT patients. Of note, <italic>Mecp2<sup>–/y</sup></italic> cortex demonstrated a significant reduction in Kir4.1 expression, not a complete loss, as would be the case in a <italic>Kcnj10</italic>-knockout animal. Although Kir4.1 currents are downregulated in <italic>Mecp2<sup>–/y</sup></italic> mice, the resting membrane potential of the astrocytes appear unaltered. This may be due to other compensatory K<sup>+</sup> channel regulation in astrocytes.</p>
</sec>
<sec id="s5B">
<title>Impaired developmental regulation of Kir4.1 in RTT mice</title>
<p>Kir4.1 protein and mRNA expression are strongly developmentally up-regulated in all brain regions, with highest expression observed in caudal brain structures (<xref ref-type="bibr" rid="B49">Nwaobi et al., 2014</xref>). Throughout the CNS, the increased expression of Kir4.1 parallels the increase in MeCP2 expression and coincides with the onset of symptoms in RTT. Upregulation of Kir4.1 is directly related to the methylation status of several CpG islands found in the promoter and intronic regions of the gene (<xref ref-type="bibr" rid="B49">Nwaobi et al., 2014</xref>). Furthermore, the <italic>Kcnj10</italic> promoter is methylated at a low level and highly expressed. Given that MeCP2 is a methyl-binding protein, which is often found bound to transcriptionally active genes with low-methylated promoters (<xref ref-type="bibr" rid="B67">Yasui et al., 2007</xref>; <xref ref-type="bibr" rid="B9">Chahrour et al., 2008</xref>), we speculated that MeCP2 was a positive transcriptional regulator of the Kir4.1 gene. Indeed, loss of MeCP2 leads to decreased Kir4.1 expression. Also, we found direct physical interaction between MeCP2 and a CpG-rich island in the promoter of <italic>Kcnj10</italic> using ChIP (<xref ref-type="fig" rid="F6">Fig. 6</xref>). The data from the cultured isolated astrocytes (<xref ref-type="fig" rid="F5">Fig. 5</xref>) suggests that loss of <italic>Kcnj10</italic> mRNA is autonomous to the astrocyte and not dependent on development in the diseased CNS. This is the first example of a glia-specific gene targeted by MeCP2 and suggests that MeCP2 positively regulates <italic>Kcnj10</italic> gene transcription.</p>
<p>We demonstrate that Kir4.1 expression does not undergo a typical robust developmental upregulation when MeCP2 is absent. Kir4.1 is not downregulated, but instead never reaches normal levels, suggesting that astrocytic maturation may be altered in the absence of MeCP2. <italic>In vivo</italic>, the loss of Kir4.1 that exists before the onset of severe symptomatology in <italic>Mecp2</italic>-deficient mice indicates that it may contribute to disease progression, and not simply an epiphenomenon of a “diseased” brain.</p>
<p>The vast majority of individuals with RTT are females, yet most animals studies focus on male <italic>Mecp2</italic> mutants. The reasons for this are that (1) male mice present with earlier symptoms and more severe symptoms, and (2) the loss of MeCP2 expression is less variable in male mice. Because the <italic>Mecp2</italic> gene is on the X chromosome, mutant female mice express one WT copy of <italic>Mecp2</italic>, leading to less severe and later symptoms. Additionally, random X chromosome inactivation may lead to skewed expression of the mutant or WT allele, which can cause variable disease progression. Nevertheless, given that RTT largely affects females, we investigated Kir4.1 mRNA expression in aged symptomatic female animals and show a loss of <italic>Kcnj10</italic> transcript similar to that observed in males.</p>
</sec>
<sec id="s5C">
<title>Kir4.1/<italic>Kcnj10</italic> dysregulation in Mecp2<sup>–/y</sup> mice: from direct interaction to function</title>
<p>Transcriptomic and, more recently, proteomic studies have begun to shed light on gene and protein disruption in human patients and animal models of RTT (<xref ref-type="bibr" rid="B12">Colantuoni et al., 2001</xref>; <xref ref-type="bibr" rid="B28">Jordan et al., 2007</xref>; <xref ref-type="bibr" rid="B9">Chahrour et al., 2008</xref>; <xref ref-type="bibr" rid="B64">Urdinguio et al., 2008</xref>; <xref ref-type="bibr" rid="B4">Ben-Shachar et al., 2009</xref>; <xref ref-type="bibr" rid="B23">Gibson et al., 2010</xref>; <xref ref-type="bibr" rid="B21">Gabel et al., 2015</xref>; <xref ref-type="bibr" rid="B21">Gabel et al., 2015</xref>; <xref ref-type="bibr" rid="B37">Lin et al., 2016</xref>). Although no study has systematically evaluated astrocytes, a recent publication indicates that 46 of 391 differentially expressed genes are uniquely astrocytic, including Kir4.1 (Pacheco et al., 2017). The changes in astrocyte gene expression do not indicate a typical reactive gliosis as seen in most neurologic diseases, because in RTT tissue many markers associated with reactive gliosis are downregulated. Intriguingly, several disrupted genes are developmentally regulated, possibly indicating alterations in astrocyte maturation in the MeCP2-deficient cortex. Although numerous studies have demonstrated that MeCP2 has many neuronal targets, including Bdnf, Gabr3, Reln, Sst, and Creb1 (<xref ref-type="bibr" rid="B61">Singh et al., 2008</xref>), here we show for the first time that one such critical astrocytic gene, <italic>Kcnj10</italic>, is a direct molecular target of MeCP2.</p>
<p>Importantly, we also show the first electrophysiological studies performed in astrocytes indicating that normal membrane currents are affected in a mouse model of RTT. These data may shed light on the role of astrocytes in RTT and indicate that astrocytes and Kir4.1 may represent novel therapeutic targets for the treatment of RTT.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>Acknowledgments: We thank Lucas Pozzo-Miller, PhD, and Wei Li, PhD, for animals.</p>
</ack>
<ref-list content-type="nameDate">
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<string-name><surname>Asaka</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Jugloff</surname>
<given-names>DGM</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Eubanks</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Fitzsimonds</surname>
<given-names>RM</given-names></string-name> (<year>2006</year>) <article-title>Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome</article-title>. <source/>Neurobiol Dis
<volume>21</volume>:<fpage>217</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2005.07.005</pub-id><pub-id pub-id-type="pmid">16087343</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<string-name><surname>Ballas</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Lioy</surname>
<given-names>DT</given-names></string-name>, <string-name><surname>Grunseich</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mandel</surname>
<given-names>G</given-names></string-name> (<year>2009</year>) <article-title>Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology</article-title>. <source/>Nat Neurosci
<volume>12</volume>:<fpage>311</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2275</pub-id>
<pub-id pub-id-type="pmid">19234456</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<string-name><surname>Batiuk</surname>
<given-names>MY</given-names></string-name>, <string-name><surname>de Vin</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Duqué</surname>
<given-names>SI</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Saito</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Saido</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Fiers</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Belgard</surname>
<given-names>TG</given-names></string-name>, <string-name><surname>Holt</surname>
<given-names>MG</given-names></string-name> (<year>2017</year>) <article-title>An immunoaffinity-based method for isolating ultrapure adult astrocytes based on ATP1B2 targeting by the ACSA-2 antibody</article-title>. <source/>J Biol Chem
<volume>292</volume>:<fpage>8874</fpage>–<lpage>8891</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.765313</pub-id>
<pub-id pub-id-type="pmid">28373281</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<string-name><surname>Ben-Shachar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chahrour</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Thaller</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Shaw</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Zoghbi</surname>
<given-names>HY</given-names></string-name> (<year>2009</year>) <article-title>Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus</article-title>. <source/>Hum Mol Genet
<volume>18</volume>:<fpage>2431</fpage>–<lpage>2442</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp181</pub-id>
<pub-id pub-id-type="pmid">19369296</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<string-name><surname>Bockenhauer</surname>
<given-names>D</given-names></string-name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations</article-title>. <source/>N Engl J Med
<volume>360</volume>:<fpage>1960</fpage>–<lpage>1970</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0810276</pub-id>
<pub-id pub-id-type="pmid">19420365</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<string-name><surname>Bushong</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Martone</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Ellisman</surname>
<given-names>MH</given-names></string-name> (<year>2004</year>) <article-title>Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development</article-title>. <source/>Int J Dev Neurosci
<volume>22</volume>:<fpage>73</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2003.12.008</pub-id>
<pub-id pub-id-type="pmid">15036382</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<string-name><surname>Calfa</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Percy</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Pozzo-Miller</surname>
<given-names>L</given-names></string-name> (<year>2011a</year>) <article-title>Experimental models of Rett syndrome based on Mecp2 dysfunction</article-title>. <source/>Exp Biol Med
<volume>236</volume>:<fpage>3</fpage>–<lpage>19</lpage>.
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<string-name><surname>Calfa</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Hablitz</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Pozzo-Miller</surname>
<given-names>L</given-names></string-name> (<year>2011b</year>) <article-title>Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging</article-title>. <source/>J Neurophysiol
<volume>105</volume>:<fpage>1768</fpage>–<lpage>1784</lpage>.
<pub-id pub-id-type="pmid">21307327</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<string-name><surname>Chahrour</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jung</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Shaw</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>STC</given-names></string-name>, <string-name><surname>Qin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zoghbi</surname>
<given-names>HY</given-names></string-name> (<year>2008</year>) <article-title>MeCP2, a key contributor to neurological disease, activates and represses transcription</article-title>. <source/>Science
<volume>320</volume>:<fpage>1224</fpage>–<lpage>1229</lpage>. <pub-id pub-id-type="doi">10.1126/science.1153252</pub-id><pub-id pub-id-type="pmid">18511691</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<string-name><surname>Chen</surname>
<given-names>RZ</given-names></string-name>, <string-name><surname>Akbarian</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Tudor</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jaenisch</surname>
<given-names>R</given-names></string-name> (<year>2001</year>) <article-title>Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice</article-title>. <source/>Nat Genet
<volume>27</volume>:<fpage>327</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1038/85906</pub-id><pub-id pub-id-type="pmid">11242118</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<string-name><surname>Chever</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Djukic</surname>
<given-names>B</given-names></string-name>, <string-name><surname>McCarthy</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Amzica</surname>
<given-names>F</given-names></string-name> (<year>2010</year>) <article-title>Implication of Kir4.1 channel in excess potassium clearance: an in vivo study on anesthetized glial-conditional Kir4.1 knock-out mice</article-title>. <source/>J Neurosci
<volume>30</volume>:<fpage>15769</fpage>–<lpage>15777</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2078-10.2010</pub-id><pub-id pub-id-type="pmid">21106816</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<string-name><surname>Colantuoni</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Jeon</surname>
<given-names>OH</given-names></string-name>, <string-name><surname>Hyder</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Chenchik</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Khimani</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Narayanan</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Hoffman</surname>
<given-names>EP</given-names></string-name>, <string-name><surname>Kaufmann</surname>
<given-names>WE</given-names></string-name>, <string-name><surname>Naidu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pevsner</surname>
<given-names>J</given-names></string-name> (<year>2001</year>) <article-title>Gene expression profiling in postmortem rett syndrome brain: differential gene expression and patient classification</article-title>. <source/>Neurobiology of Disease
<volume>8</volume>:<fpage>847</fpage>–<lpage>865</lpage>. <pub-id pub-id-type="doi">10.1006/nbdi.2001.0428</pub-id><pub-id pub-id-type="pmid">11592853</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<string-name><surname>Colic</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wither</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Eubanks</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bardakjian</surname>
<given-names>BL</given-names></string-name> (<year>2011</year>) <article-title>EEG analysis for estimation of duration and inter-event intervals of seizure-like events recorded in vivo from mice</article-title>. <source/>Conf Proc IEEE Eng Med Biol Soc
<volume>2011</volume>:<fpage>2570</fpage>–<lpage>2573</lpage>. <pub-id pub-id-type="doi">10.1109/IEMBS.2011.6090710</pub-id>
<pub-id pub-id-type="pmid">22254866</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<string-name><surname>Cuddapah</surname>
<given-names>VA</given-names></string-name>, <string-name><surname>Pillai</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Shekar</surname>
<given-names>KV</given-names></string-name>, <string-name><surname>Lane</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Motil</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Skinner</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Tarquinio</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Glaze</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>McGwin</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Kaufmann</surname>
<given-names>WE</given-names></string-name>, <string-name><surname>Percy</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Neul</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Olsen</surname>
<given-names>ML</given-names></string-name> (<year>2014</year>) <article-title>Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome</article-title>. <source/>J Med Genet
<volume>51</volume>:<fpage>152</fpage>–<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2013-102113</pub-id>
<pub-id pub-id-type="pmid">24399845</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<string-name><surname>D’Ambrosio</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gordon</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Winn</surname>
<given-names>HR</given-names></string-name> (<year>2002</year>) <article-title>Differential role of KIR channel and Na(+)/K(+)-pump in the regulation of extracellular K(+) in rat hippocampus</article-title>. <source/>J Neurophysiol
<volume>87</volume>:<fpage>87</fpage>–<lpage>102</lpage>.
<pub-id pub-id-type="pmid">11784732</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<string-name><surname>D’Cruz</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zahid</surname>
<given-names>T</given-names></string-name>, <string-name><surname>El-Hayek</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Eubanks</surname>
<given-names>JH</given-names></string-name> (<year>2010</year>) <article-title>Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice</article-title>. <source/>Neurobiol Dis
<volume>38</volume>:<fpage>8</fpage>–<lpage>16</lpage>.
<pub-id pub-id-type="pmid">20045053</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<string-name><surname>Dani</surname>
<given-names>VS</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>SB</given-names></string-name> (<year>2009</year>) <article-title>Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome</article-title>. <source/>J Neurosci
<volume>29</volume>:<fpage>11263</fpage>–<lpage>11270</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1019-09.2009</pub-id><pub-id pub-id-type="pmid">19741133</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<string-name><surname>Dani</surname>
<given-names>VS</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Maffei</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Turrigiano</surname>
<given-names>GG</given-names></string-name>, <string-name><surname>Jaenisch</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>SB</given-names></string-name> (<year>2005</year>) <article-title>Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>102</volume>:<fpage>12560</fpage>–<lpage>12565</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506071102</pub-id><pub-id pub-id-type="pmid">16116096</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<string-name><surname>Derecki</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Cronk</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Abbott</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Guyenet</surname>
<given-names>PG</given-names></string-name>, <string-name><surname>Kipnis</surname>
<given-names>J</given-names></string-name> (<year>2012</year>) <article-title>Wild-type microglia arrest pathology in a mouse model of Rett syndrome</article-title>. <source/>Nature
<volume>484</volume>:<fpage>105</fpage>–<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1038/nature10907</pub-id><pub-id pub-id-type="pmid">22425995</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<string-name><surname>Djukic</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Casper</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Philpot</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Chin</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>McCarthy</surname>
<given-names>KD</given-names></string-name> (<year>2007</year>) <article-title>Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation</article-title>. <source/>J Neurosci
<volume>27</volume>:<fpage>11354</fpage>–<lpage>11365</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0723-07.2007</pub-id>
<pub-id pub-id-type="pmid">17942730</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<string-name><surname>Gabel</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Kinde</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Stroud</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Gilbert</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Harmin</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Kastan</surname>
<given-names>NR</given-names></string-name>, <string-name><surname>Hemberg</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ebert</surname>
<given-names>DH</given-names></string-name>, <string-name><surname>Greenberg</surname>
<given-names>ME</given-names></string-name> (<year>2015</year>) <article-title>Disruption of DNA-methylation-dependent long gene repression in Rett syndrome</article-title>. <source/>Nature
<volume>522</volume>:<fpage>89</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/nature14319</pub-id>
<pub-id pub-id-type="pmid">25762136</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<string-name><surname>Garg</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Lioy</surname>
<given-names>DT</given-names></string-name>, <string-name><surname>Knopp</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Bissonnette</surname>
<given-names>JM</given-names></string-name> (<year>2015</year>) <article-title>Conditional depletion of methyl-CpG-binding protein 2 in astrocytes depresses the hypercapnic ventilatory response in mice</article-title>. <source/>J Appl Physiol
<volume>119</volume>:<fpage>670</fpage>–<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00411.2015</pub-id><pub-id pub-id-type="pmid">26205541</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<string-name><surname>Gibson</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Slobedman</surname>
<given-names>B</given-names></string-name>, <string-name><surname>KN</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Williamson</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Minchenko</surname>
<given-names>D</given-names></string-name>, <string-name><surname>El-Osta</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Stern</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Christodoulou</surname>
<given-names>J</given-names></string-name> (<year>2010</year>) <article-title>Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain</article-title>. <source/>BMC Neurosci
<volume>11</volume>:<fpage>53.</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2202-11-53</pub-id><pub-id pub-id-type="pmid">20420693</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<string-name><surname>Glaze</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Percy</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Skinner</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Motil</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Neul</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Barrish</surname>
<given-names>JO</given-names></string-name>, <string-name><surname>Lane</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Geerts</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Annese</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Graham</surname>
<given-names>J</given-names></string-name>, <string-name><surname>McNair</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>HS</given-names></string-name> (<year>2010</year>) <article-title>Epilepsy and the natural history of Rett syndrome</article-title>. <source/>Neurology
<volume>74</volume>:<fpage>909</fpage>–<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181d6b852</pub-id>
<pub-id pub-id-type="pmid">20231667</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<string-name><surname>Guy</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hendrich</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Holmes</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Bird</surname>
<given-names>A</given-names></string-name> (<year>2001</year>) <article-title>A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome</article-title>. <source/>Nat Genet
<volume>27</volume>:<fpage>322</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1038/85899</pub-id><pub-id pub-id-type="pmid">11242117</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<string-name><surname>Holt</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Olsen</surname>
<given-names>ML</given-names></string-name> (<year>2016</year>) <article-title>Novel applications of magnetic cell sorting to analyze cell-type specific gene and protein expression in the central nervous system</article-title>. <source/>PLoS One
<volume>11</volume>:<fpage>e0150290.</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0150290</pub-id>
<pub-id pub-id-type="pmid">26919701</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<string-name><surname>Jian</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Nagarajan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>de</surname>
<given-names>KN</given-names></string-name>, <string-name><surname>Ravine</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Christodoulou</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Leonard</surname>
<given-names>H</given-names></string-name> (<year>2007</year>) <article-title>Seizures in Rett syndrome: an overview from a one-year calendar study</article-title>. <source/>Eur J Paediatr Neurol
<volume>11</volume>:<fpage>310</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpn.2007.02.008</pub-id>
<pub-id pub-id-type="pmid">17433737</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<string-name><surname>Jordan</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>HH</given-names></string-name>, <string-name><surname>Kwan</surname>
<given-names>HC</given-names></string-name>, <string-name><surname>Francke</surname>
<given-names>U</given-names></string-name> (<year>2007</year>) <article-title>Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets</article-title>. <source/>BMC Med Genet
<volume>8</volume>:<fpage>36.</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2350-8-36</pub-id>
<pub-id pub-id-type="pmid">17584923</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<string-name><surname>Kantzer</surname>
<given-names>CG</given-names></string-name>, <string-name><surname>Boutin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Herzig</surname>
<given-names>ID</given-names></string-name>, <string-name><surname>Wittwer</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Reiß</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Tiveron</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Drewes</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Rockel</surname>
<given-names>TD</given-names></string-name>, <string-name><surname>Ohlig</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ninkovic</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Cremer</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Pennartz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jungblut</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bosio</surname>
<given-names>A</given-names></string-name> (<year>2017</year>) <article-title>Anti-ACSA-2 defines a novel monoclonal antibody for prospective isolation of living neonatal and adult astrocytes</article-title>. <source/>Glia
<volume>65</volume>:<fpage>990</fpage>–<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1002/glia.23140</pub-id>
<pub-id pub-id-type="pmid">28317180</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<string-name><surname>Kifayathullah</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Arunachalam</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Bodda</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Agbemenyah</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Laccone</surname>
<given-names>FA</given-names></string-name>, <string-name><surname>Mannan</surname>
<given-names>AU</given-names></string-name> (<year>2010</year>) <article-title>MeCP<sup>2270</sup> mutant protein is expressed in astrocytes as well as in neurons and localizes in the nucleus</article-title>. <source/>Cytogenet Genome Res
<volume>129</volume>:<fpage>290</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1159/000315906</pub-id>
<pub-id pub-id-type="pmid">20625242</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<string-name><surname>Kishi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Macklis</surname>
<given-names>JD</given-names></string-name> (<year>2004</year>) <article-title>MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions</article-title>. <source/>Mol Cell Neurosci
<volume>27</volume>:<fpage>306</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2004.07.006</pub-id>
<pub-id pub-id-type="pmid">15519245</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<string-name><surname>Kofuji</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Newman</surname>
<given-names>EA</given-names></string-name> (<year>2004</year>) <article-title>Potassium buffering in the central nervous system</article-title>. <source/>Neuroscience
<volume>129</volume>:<fpage>1043</fpage>–<lpage>1054</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.06.008</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<string-name><surname>Kofuji</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ceelen</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Zahs</surname>
<given-names>KR</given-names></string-name>, <string-name><surname>Surbeck</surname>
<given-names>LW</given-names></string-name>, <string-name><surname>Lester</surname>
<given-names>HA</given-names></string-name>, <string-name><surname>Newman</surname>
<given-names>EA</given-names></string-name> (<year>2000</year>) <article-title>Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina</article-title>. <source/>J Neurosci
<volume>20</volume>:<fpage>5733</fpage>–<lpage>5740</lpage>.
<pub-id pub-id-type="pmid">10908613</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<string-name><surname>Kuffler</surname>
<given-names>SW</given-names></string-name> (<year>1967</year>) <article-title>The Ferrier Lecture: Neuroglial cells: physiological properties and a potassium mediated effect of neuronal activity on the glial membrane potential</article-title>. <source/>Proc R Soc Lond Ser B Biol Sci
<volume>168</volume>:<fpage>1</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1098/rspb.1967.0047</pub-id><pub-id pub-id-type="pmid">4382871</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<string-name><surname>Kuffler</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Potter</surname>
<given-names>DD</given-names></string-name> (<year>1964</year>) <article-title>GLIA in the leech central nervous system: physiological properties and neuron-GLIA relationship</article-title>. <source/>J Neurophysiol
<volume>27</volume>:<fpage>290</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1964.27.2.290</pub-id>
<pub-id pub-id-type="pmid">14129773</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<string-name><surname>Li</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Calfa</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Larimore</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pozzo-Miller</surname>
<given-names>L</given-names></string-name> (<year>2012</year>) <article-title>Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>109</volume>:<fpage>17087</fpage>–<lpage>17092</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1205271109</pub-id>
<pub-id pub-id-type="pmid">23027959</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<string-name><surname>Lin</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Nicholls</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Assareh</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Amos</surname>
<given-names>TG</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Assareh</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Voineagu</surname>
<given-names>I</given-names></string-name> (<year>2016</year>) <article-title>Transcriptome analysis of human brain tissue identifies reduced expression of complement complex C1Q genes in Rett syndrome</article-title>. <source/>BMC Genomics
<volume>17</volume>:<fpage>427.</fpage>
<pub-id pub-id-type="doi">10.1186/s12864-016-2746-7</pub-id>
<pub-id pub-id-type="pmid">27267200</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<string-name><surname>Lioy</surname>
<given-names>DT</given-names></string-name>, <string-name><surname>Garg</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Monaghan</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Raber</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Foust</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>Kaspar</surname>
<given-names>BK</given-names></string-name>, <string-name><surname>Hirrlinger</surname>
<given-names>PG</given-names></string-name>, <string-name><surname>Kirchhoff</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Bissonnette</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Ballas</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Mandel</surname>
<given-names>G</given-names></string-name> (<year>2011</year>) <article-title>A role for glia in the progression of Rett’s syndrome</article-title>. <source/>Nature
<volume>475</volume>:<fpage>497</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1038/nature10214</pub-id>
<pub-id pub-id-type="pmid">21716289</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<string-name><surname>Liu</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ni</surname>
<given-names>J-J</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>F-Y</given-names></string-name> (<year>2017</year>) <article-title>Expression of phospho-MeCP2s in the developing rat brain and function of postnatal MeCP2 in cerebellar neural cell development</article-title>. <source/>Neurosci Bull
<volume>33</volume>:<fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-016-0086-x</pub-id>
<pub-id pub-id-type="pmid">27995568</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<string-name><surname>Liu</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ni</surname>
<given-names>J-J</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>J-J</given-names></string-name>, <string-name><surname>Kou</surname>
<given-names>Z-W</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>F-Y</given-names></string-name> (<year>2015</year>) <article-title>VEGF overexpression enhances the accumulation of phospho-S292 MeCP2 in reactive astrocytes in the adult rat striatum following cerebral ischemia</article-title>. <source/>Brain Res
<volume>1599</volume>:<fpage>32</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2014.12.014</pub-id>
<pub-id pub-id-type="pmid">25511996</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<string-name><surname>Ma</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Enyeart</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>M</given-names></string-name> (<year>2014</year>) <article-title>Dual patch voltage clamp study of low membrane resistance astrocytes in situ</article-title>. <source/>Mol Brain
<volume>7</volume>:<fpage>18.</fpage>
<pub-id pub-id-type="doi">10.1186/1756-6606-7-18</pub-id>
<pub-id pub-id-type="pmid">24636341</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<string-name><surname>Maezawa</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>LW</given-names></string-name> (<year>2010</year>) <article-title>Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate</article-title>. <source/>J Neurosci
<volume>30</volume>:<fpage>5346</fpage>–<lpage>5356</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5966-09.2010</pub-id>
<pub-id pub-id-type="pmid">20392956</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<string-name><surname>Maezawa</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Swanberg</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Harvey</surname>
<given-names>D</given-names></string-name>, <string-name><surname>LaSalle</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>LW</given-names></string-name> (<year>2009</year>) <article-title>Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions</article-title>. <source/>J Neurosci
<volume>29</volume>:<fpage>5051</fpage>–<lpage>5061</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0324-09.2009</pub-id>
<pub-id pub-id-type="pmid">19386901</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<string-name><surname>McLeod</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ganley</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Selfridge</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bird</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cobb</surname>
<given-names>SR</given-names></string-name> (<year>2013</year>) <article-title>Reduced seizure threshold and altered network oscillatory properties in a mouse model of Rett syndrome</article-title>. <source/>Neuroscience
<volume>231</volume>:<fpage>195</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.11.058</pub-id><pub-id pub-id-type="pmid">23238573</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<string-name><surname>Moretti</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Levenson</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Battaglia</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Atkinson</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Teague</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Antalffy</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Armstrong</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Arancio</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Sweatt</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Zoghbi</surname>
<given-names>HY</given-names></string-name> (<year>2006</year>) <article-title>Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome</article-title>. <source/>J Neurosci
<volume>26</volume>:<fpage>319</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2623-05.2006</pub-id>
<pub-id pub-id-type="pmid">16399702</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<string-name><surname>Nectoux</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Florian</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Delepine</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bahi-Buisson</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Khelfaoui</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Reibel</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chelly</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bienvenu</surname>
<given-names>T</given-names></string-name> (<year>2012</year>) <article-title>Altered microtubule dynamics in Mecp2-deficient astrocytes</article-title>. <source/>J Neurosci Res
<volume>90</volume>:<fpage>990</fpage>–<lpage>998</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23001</pub-id>
<pub-id pub-id-type="pmid">22252744</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<string-name><surname>Neul</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Kaufmann</surname>
<given-names>WE</given-names></string-name>, <string-name><surname>Glaze</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Christodoulou</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Clarke</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Bahi-Buisson</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Leonard</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Bailey</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Schanen</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Zappella</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Renieri</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Huppke</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Percy</surname>
<given-names>AK</given-names></string-name> (<year>2010</year>) <article-title>Rett syndrome: revised diagnostic criteria and nomenclature</article-title>. <source/>Ann Neurol
<volume>68</volume>:<fpage>944</fpage>–<lpage>950</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22124</pub-id>
<pub-id pub-id-type="pmid">21154482</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<string-name><surname>Neusch</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Papadopoulos</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Müller</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Maletzki</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Winter</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Hirrlinger</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Handschuh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bähr</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Richter</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Kirchhoff</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Hülsmann</surname>
<given-names>S</given-names></string-name> (<year>2006</year>) <article-title>Lack of the Kir4.1 channel subunit abolishes K+ buffering properties of astrocytes in the ventral respiratory group: impact on extracellular K+ regulation</article-title>. <source/>J Neurophysiol
<volume>95</volume>:<fpage>1843</fpage>–<lpage>1852</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00996.2005</pub-id>
<pub-id pub-id-type="pmid">16306174</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<string-name><surname>Nwaobi</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Peramsetty</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Olsen</surname>
<given-names>ML</given-names></string-name> (<year>2014</year>) <article-title>DNA methylation functions as a critical regulator of Kir4.1 expression during CNS development</article-title>. <source/>Glia
<volume>62</volume>:<fpage>411</fpage>–<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22613</pub-id>
<pub-id pub-id-type="pmid">24415225</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<string-name><surname>Nwaobi</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Cuddapah</surname>
<given-names>VA</given-names></string-name>, <string-name><surname>Patterson</surname>
<given-names>KC</given-names></string-name>, <string-name><surname>Randolph</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Olsen</surname>
<given-names>ML</given-names></string-name> (<year>2016</year>) <article-title>The role of glial-specific Kir4.1 in normal and pathological states of the CNS</article-title>. <source/>Acta Neuropathol
<volume>132</volume>:<fpage>1</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-016-1553-1</pub-id><pub-id pub-id-type="pmid">26961251</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<string-name><surname>Okabe</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Takahashi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mitsumasu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kosai</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tanaka</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Matsuishi</surname>
<given-names>T</given-names></string-name> (<year>2012</year>) <article-title>Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome</article-title>. <source/>PLoS One
<volume>7</volume>:<fpage>e35354.</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0035354</pub-id>
<pub-id pub-id-type="pmid">22532851</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<string-name><surname>Olsen</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Higashimori</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Campbell</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Hablitz</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Sontheimer</surname>
<given-names>H</given-names></string-name> (<year>2006</year>) <article-title>Functional expression of Kir4.1 channels in spinal cord astrocytes</article-title>. <source/>Glia
<volume>53</volume>:<fpage>516</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20312</pub-id>
<pub-id pub-id-type="pmid">16369934</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<string-name><surname>Orkand</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Nicholls</surname>
<given-names>JG</given-names></string-name>, <string-name><surname>Kuffler</surname>
<given-names>SW</given-names></string-name> (<year>1966</year>) <article-title>Effect of nerve impulses on the membrane potential of glial cells in the central nervous system of amphibia</article-title>. <source/>J Neurophysiol
<volume>29</volume>:<fpage>788</fpage>–<lpage>806</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1966.29.4.788</pub-id><pub-id pub-id-type="pmid">5966435</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<string-name><surname>Percy</surname>
<given-names>AK</given-names></string-name> (<year>2002</year>) <article-title>Rett syndrome. Current status and new vistas</article-title>. <source/>Neurol Clin
<volume>20</volume>:<fpage>1125</fpage>–<lpage>1141</lpage>. <pub-id pub-id-type="pmid">12616684</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<string-name><surname>Ransom</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Sontheimer</surname>
<given-names>H</given-names></string-name> (<year>1995</year>) <article-title>Biophysical and pharmacological characterization of inwardly rectifying K+ currents in rat spinal cord astrocytes</article-title>. <source/>J Neurophysiol
<volume>73</volume>:<fpage>333</fpage>–<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1995.73.1.333</pub-id><pub-id pub-id-type="pmid">7714576</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<string-name><surname>Ransom</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Ransom</surname>
<given-names>BR</given-names></string-name>, <string-name><surname>Sontheimer</surname>
<given-names>H</given-names></string-name> (<year>2000</year>) <article-title>Activity-dependent extracellular K+ accumulation in rat optic nerve: the role of glial and axonal Na+ pumps</article-title>. <source/>J Physiol
<volume>522</volume>:<fpage>427</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.00427.x</pub-id><pub-id pub-id-type="pmid">10713967</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<string-name><surname>Sajan</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Jhangiani</surname>
<given-names>SN</given-names></string-name>, <string-name><surname>Muzny</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Gibbs</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Lupski</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Glaze</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Kaufmann</surname>
<given-names>WE</given-names></string-name>, <string-name><surname>Skinner</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Annese</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Friez</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Lane</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Percy</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Neul</surname>
<given-names>JL</given-names></string-name> (<year>2017</year>) <article-title>Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2</article-title>. <source/>Genet Med
<volume>19</volume>:<fpage>13</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2016.42</pub-id><pub-id pub-id-type="pmid">27171548</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<string-name><surname>Scholl</surname>
<given-names>UI</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ramaekers</surname>
<given-names>VT</given-names></string-name>, <string-name><surname>Häusler</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Grimmer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tobe</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Farhi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nelson-Williams</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Lifton</surname>
<given-names>RP</given-names></string-name> (<year>2009</year>) <article-title>Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>106</volume>:<fpage>5842</fpage>–<lpage>5847</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0901749106</pub-id>
<pub-id pub-id-type="pmid">19289823</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<string-name><surname>Seifert</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Hüttmann</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Binder</surname>
<given-names>DK</given-names></string-name>, <string-name><surname>Hartmann</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wyczynski</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Neusch</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Steinhauser</surname>
<given-names>C</given-names></string-name> (<year>2009</year>) <article-title>Analysis of astroglial K+ channel expression in the developing hippocampus reveals a predominant role of the Kir4.1 subunit</article-title>. <source/>J Neurosci
<volume>29</volume>:<fpage>7474</fpage>–<lpage>7488</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3790-08.2009</pub-id>
<pub-id pub-id-type="pmid">19515915</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<string-name><surname>Sicca</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Imbrici</surname>
<given-names>P</given-names></string-name>, <string-name><surname>D’Adamo</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Moro</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Bonatti</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Brovedani</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Grottesi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Guerrini</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Masi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Santorelli</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Pessia</surname>
<given-names>M</given-names></string-name> (<year>2011</year>) <article-title>Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1</article-title>. <source/>Neurobiol Dis
<volume>43</volume>:<fpage>239</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2011.03.016</pub-id>
<pub-id pub-id-type="pmid">21458570</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<string-name><surname>Singh</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Saxena</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Christodoulou</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ravine</surname>
<given-names>D</given-names></string-name> (<year>2008</year>) <article-title>MECP2 genomic structure and function: insights from ENCODE</article-title>. <source/>Nucleic Acids Res
<volume>36</volume>:<fpage>6035</fpage>–<lpage>6047</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn591</pub-id>
<pub-id pub-id-type="pmid">18820302</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<string-name><surname>Smrt</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Pfeiffer</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>X</given-names></string-name> (<year>2011</year>) <article-title>Age-dependent expression of MeCP2 in a heterozygous mosaic mouse model</article-title>. <source/>Hum Mol Genet
<volume>20</volume>:<fpage>1834</fpage>–<lpage>1843</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr066</pub-id><pub-id pub-id-type="pmid">21330301</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<string-name><surname>Tong</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Faas</surname>
<given-names>GC</given-names></string-name>, <string-name><surname>Nwaobi</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Haustein</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Mody</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Olsen</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Sofroniew</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>Khakh</surname>
<given-names>BS</given-names></string-name> (<year>2014</year>) <article-title>Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington’s disease model mice</article-title>. <source/>Nat Neurosci
<volume>17</volume>:<fpage>694</fpage>–<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3691</pub-id>
<pub-id pub-id-type="pmid">24686787</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<string-name><surname>Urdinguio</surname>
<given-names>RG</given-names></string-name>, <string-name><surname>Lopez-Serra</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lopez-Nieva</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Alaminos</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Diaz-Uriarte</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Fernandez</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Esteller</surname>
<given-names>M</given-names></string-name> (<year>2008</year>) <article-title>Mecp2-null mice provide new neuronal targets for Rett syndrome</article-title>. <source/>PLoS One
<volume>3</volume>:<fpage>e3669.</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0003669</pub-id>
<pub-id pub-id-type="pmid">18989361</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<string-name><surname>Williams</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Zhong</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Mohamed</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Ananiev</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Mok</surname>
<given-names>JCC</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>BR</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Chiao</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Cherney</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>S-C</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>Q</given-names></string-name> (<year>2014</year>) <article-title>Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons</article-title>. <source/>Hum Mol Genet
<volume>23</volume>:<fpage>2968</fpage>–<lpage>2980</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu008</pub-id><pub-id pub-id-type="pmid">24419315</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<string-name><surname>Wood</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Gray</surname>
<given-names>NW</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Greenberg</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Shepherd</surname>
<given-names>GMG</given-names></string-name> (<year>2009</year>) <article-title>Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency</article-title>. <source/>J Neurosci
<volume>29</volume>:<fpage>12440</fpage>–<lpage>12448</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3321-09.2009</pub-id><pub-id pub-id-type="pmid">19812320</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<string-name><surname>Yasui</surname>
<given-names>DH</given-names></string-name>, <string-name><surname>Peddada</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bieda</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Vallero</surname>
<given-names>RO</given-names></string-name>, <string-name><surname>Hogart</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nagarajan</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Thatcher</surname>
<given-names>KN</given-names></string-name>, <string-name><surname>Farnham</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Lasalle</surname>
<given-names>JM</given-names></string-name> (<year>2007</year>) <article-title>Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>104</volume>:<fpage>19416</fpage>–<lpage>19421</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0707442104</pub-id>
<pub-id pub-id-type="pmid">18042715</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<string-name><surname>Zachariah</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Olson</surname>
<given-names>CO</given-names></string-name>, <string-name><surname>Ezeonwuka</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rastegar</surname>
<given-names>M</given-names></string-name> (<year>2012</year>) <article-title>Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes</article-title>. <source/>PLoS One
<volume>7</volume>:<fpage>e49763.</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0049763</pub-id>
<pub-id pub-id-type="pmid">23185431</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>He</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jugloff</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Eubanks</surname>
<given-names>JH</given-names></string-name> (<year>2008</year>) <article-title>The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability</article-title>. <source/>Hippocampus
<volume>18</volume>:<fpage>294</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.20389</pub-id>
<pub-id pub-id-type="pmid">18058824</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Cui</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tadepalli</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Sekizar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>C</given-names></string-name> (<year>2010</year>) <article-title>Intrinsic membrane properties of locus coeruleus neurons in Mecp2-null mice</article-title>. <source/>Am J Physiol Cell Physiol
<volume>298</volume>:<fpage>C635</fpage>–<lpage>C646</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00442.2009</pub-id><pub-id pub-id-type="pmid">20042730</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<string-name><surname>Zheng</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Stornetta</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Agassandian</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Rinaman</surname>
<given-names>L</given-names></string-name> (<year>2014</year>) <article-title>Glutamatergic phenotype of glucagon-like peptide 1 neurons in the caudal nucleus of the solitary tract in rats</article-title>. <source/>Brain Struct Funct
<volume>220</volume>:<fpage>3011</fpage>–<lpage>3022</lpage>.
<pub-id pub-id-type="pmid">25012114</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<string-name><surname>Zhou</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schools</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Kimelberg</surname>
<given-names>HK</given-names></string-name> (<year>2006</year>) <article-title>Development of GLAST(+) astrocytes and NG2(+) glia in rat hippocampus CA1: mature astrocytes are electrophysiologically passive</article-title>. <source/>J Neurophysiol
<volume>95</volume>:<fpage>134</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00570.2005</pub-id>
<pub-id pub-id-type="pmid">16093329</pub-id></mixed-citation>
</ref>
</ref-list>
<sec id="s6" sec-type="synthesis-author-response">
<title>Synthesis</title>
<boxed-text orientation="portrait" position="float">
<p>Reviewing Editor: Tallie Z. Baram, University of California-Irvine</p>
<p>Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: Tim Benke.</p>
</boxed-text>
<p>The manuscript in its revised form now presents convincing evidence to support down-regulation of Kir4.1 in astrocytes of MECP2-impaired animals, in an autonomous fashion. Considering the potential relevance to MECP2 impairment to Rett syndrome and the need to identify cellular pathways for potential therapeutic strategies, these findings should be of significant interest readership.</p>
<p>Thus, thee reviewers of the revised paper found it worthy of publication in eNeuro- and i concur heartily. One of the reviewers requested additional minor improvements, and i include these below. Upon completion of these, we will accept the paper. Thank you for working with us!</p>
<p>There are several remaining technical inconsistencies and inaccuracies that should be addressed:</p>
<p>1. Fig 4B: a p-value smaller than 0.05 is probably impossible to achieve with a 2-tailed unpaired t-test, based on the values reported (33% reduction with a standard error of 25%, see line 318 as well as the histogram). By entering these values into a statistical program (such as GraphPad Prism), one can see that even with a zero standard error of the control group (wildtype), the p-value would have still been ~0.2, way above the reported &lt;0.05. The authors should clarify this discrepancy. If this is indeed statistically insignificant, the authors should modify the figure and text accordingly.</p>
<p>2. Line 294-295: "these higher molecular weight bands are absent in MECP2 deficient mice". Since higher bands are observable for these mice (Fig 3A), this statement should be altered to reflect reduced intensity rather than elimination of these bands.</p>
<p>3. Figure 5, legend (lines 689-690): "By 14 days in culture astrocytes express similar levels of astrocyte markers GFAP and Kir4.1 as observed in age-matched cortex". This is not supported by the data as presented (an increase is observed in Fig5B, which is expected considering that the cortex sample is of mixed cell populations). Unless the authors have data to support this statement , it should be removed.</p>
<p>4. Line 262: "TREK-2" - the authors have probably meant TREK-1 (KCNK2) (based on Table 2 and Results, line 242).</p>
<p>5. The methods section contains references to data that has been removed from the current version (e.g. lines 94-95, 112-113, describing antibodies and PCR probes used for various genes not included in this version).</p>
<p>6. Table 2: "Astros", "oligos" (right column) should be modified to their correct terms.</p>
<p>7. Line 253, 255: "not shown" - should be removed.</p>
<p>8. Figure 5 needs some work (panel letter B is misaligned, as well as "GFAP" title in panel A).</p>
<p>9. Fig.4 legend, line 683 "Mecp2 mice 2" -seems a typo.</p>
</sec>
</back>
</article>
</pmc-articleset>